<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">96695</article-id>
<article-id pub-id-type="doi">10.7554/eLife.96695</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.96695.1</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.2</article-version>
</article-version-alternatives>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Genetics and Genomics</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Genetic Stability of <italic>Mycobacterium smegmatis</italic> under the Stress of First-Line Antitubercular Agents: Assessing Mutagenic Potential</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Molnár</surname>
<given-names>Dániel</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a3">3</xref>
<xref ref-type="author-notes" rid="n1">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Surányi</surname>
<given-names>Éva Viola</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="author-notes" rid="n1">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Trombitás</surname>
<given-names>Tamás</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Füzesi</surname>
<given-names>Dóra</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Hirmondó</surname>
<given-names>Rita</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0965-046X</contrib-id>
<name>
<surname>Tóth</surname>
<given-names>Judit</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
<aff id="a1"><label>1</label><institution>Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences</institution>, Budapest, 1117 <country>Hungary</country></aff>
<aff id="a2"><label>2</label><institution>Department of Applied Biotechnology and Food Science, Budapest University of Technology and Economics</institution>, Budapest, 1111 <country>Hungary</country></aff>
<aff id="a3"><label>3</label><institution>Doctoral School of Biology and Institute of Biology, ELTE Eötvös Loránd University</institution>, Budapest, 1117 <country>Hungary</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Ali</surname>
<given-names>Musa</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Hawassa University</institution>
</institution-wrap>
<city>Hawassa</city>
<country>Ethiopia</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Kana</surname>
<given-names>Bavesh D</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution>University of the Witwatersrand</institution>
</institution-wrap>
<city>Johannesburg</city>
<country>South Africa</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>*</label>To whom correspondence should be addressed. Tel: +36 1382 6793; Email: <email>toth.judit@ttk.hu</email> Correspondence may also be addressed to <email>hirmondo.rita@ttk.hu</email></corresp>
<fn id="n1" fn-type="others"><label>†</label><p>Joint Authors</p></fn>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2024-05-09">
<day>09</day>
<month>05</month>
<year>2024</year>
</pub-date>
<volume>13</volume>
<elocation-id>RP96695</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2024-02-11">
<day>11</day>
<month>02</month>
<year>2024</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2024-02-27">
<day>27</day>
<month>02</month>
<year>2024</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.02.21.581394"/>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2024, Molnár et al</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Molnár et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-96695-v1.pdf"/>
<abstract>
<title>Abstract</title>
<p>The sustained success of <italic>Mycobacterium tuberculosis</italic> as a pathogen arises from its ability to persist within macrophages for extended periods and its limited responsiveness to antibiotics. Furthermore, the high incidence of resistance to the few available antituberculosis drugs is a significant concern, especially since the driving forces of the emergence of drug resistance are not clear. Drug-resistant strains of <italic>Mycobacterium tuberculosis</italic> can emerge through <italic>de novo</italic> mutations, however, mycobacterial mutation rates are low. To unravel the molecular mechanisms of antibiotic pressure on genetic variability and their impact on mycobacterial survival, we systematically explored the effects of current antibiotics on genome stability, DNA repair system activation, and the dNTP pool using <italic>Mycobacterium smegmatis</italic>. Whole-genome sequencing revealed no significant increase in mutation rates after prolonged exposure to first-line antibiotics. However, the phenotypic fluctuation assay indicated rapid adaptation to antibiotics, likely mediated by non-genetic factors. The upregulation of DNA repair genes measured using qPCR suggests that genomic integrity is maintained through the activation of specific DNA repair pathways. Our results, indicating that antibiotic exposure does not result in <italic>de novo</italic> adaptive mutagenesis under laboratory conditions, do not lend support to the model suggesting antibiotic resistance development through drug pressure-induced microevolution.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords</title>
<kwd>mutagenic pressure</kwd>
<kwd>phenotypic adaptation</kwd>
<kwd>stress response</kwd>
<kwd>antibiotic resistance</kwd>
<kwd>tuberculosis</kwd>
<kwd>polyclonal infection model</kwd>
</kwd-group>
</article-meta>
<notes>
<notes notes-type="competing-interest-statement">
<title>Competing Interest Statement</title><p>The authors have declared no competing interest.</p></notes>
<fn-group content-type="summary-of-updates">
<title>Summary of Updates:</title>
<fn fn-type="update"><p>This version of the manuscript has been revised to add the Supplemental file originally not submitted with the main text. Otherwise, the manuscript text is unchanged.</p></fn>
</fn-group>
</notes>
</front>
<body>
<sec id="s1">
<label>1.</label><title>Introduction</title>
<p>Tuberculosis (TB) continues to be the most challenging, constantly present infectious disease worldwide, with 7.5 million newly reported cases and 1.3 million deaths per year(<xref ref-type="bibr" rid="c1">1</xref>). The resurgence of TB due to the SARS-CoV-2 pandemic(<xref ref-type="bibr" rid="c1">1</xref>) underscores the interconnected nature of global health and economic issues with TB incidence and control.</p>
<p>The causative agents of TB are members of the <italic>Mycobacterium tuberculosis</italic> (<italic>M. tuberculosis</italic>) complex. These obligate pathogen bacteria can incur a sustained threat to humanity thanks to their long term latency(<xref ref-type="bibr" rid="c2">2</xref>) and highly unresponsive nature to antibiotics(<xref ref-type="bibr" rid="c3">3</xref>, <xref ref-type="bibr" rid="c4">4</xref>). Understanding the treatment evasion mechanisms and the outstanding stress tolerance of <italic>Mycobacteria</italic> are in the spotlight of TB research(<xref ref-type="bibr" rid="c5">5</xref>),(<xref ref-type="bibr" rid="c6">6</xref>). Drug tolerance arises when certain bacterial populations are temporarily able to survive antibiotic pressure in the absence of drug resistance-conferring mutations. Upon exposure to bactericidal drugs, tolerant mycobacteria are eliminated at a lower rate than the fully susceptible population(<xref ref-type="bibr" rid="c7">7</xref>). Several interconnected biological pathways are involved in the emergence and establishment of a drug-tolerant state(<xref ref-type="bibr" rid="c8">8</xref>, <xref ref-type="bibr" rid="c9">9</xref>) including metabolic slowdown, metabolic shifting, cell wall thickening and transcriptional regulation guided adaptation(<xref ref-type="bibr" rid="c10">10</xref>). For example, several efflux pumps are upregulated under antibiotic stress(<xref ref-type="bibr" rid="c11">11</xref>, <xref ref-type="bibr" rid="c12">12</xref>). In addition to temporary drug tolerance, the occurrence of genotypic resistance against the few useable antituberculotics is also recurrent(<xref ref-type="bibr" rid="c13">13</xref>). Interestingly, horizontal gene transfer, which is a major contributor to antibiotics resistance in other species does not appear to function in members of the <italic>M. tuberculosis</italic> complex(<xref ref-type="bibr" rid="c14">14</xref>, <xref ref-type="bibr" rid="c15">15</xref>). Therefore, any resistant genotype can only emerge by <italic>de novo</italic> mutagenesis.</p>
<p>It is now commonly accepted that the <italic>M. tuberculosis</italic> population within individual TB patients can be more heterogeneous than was traditionally thought(<xref ref-type="bibr" rid="c16">16</xref>, <xref ref-type="bibr" rid="c17">17</xref>). The coexistence of both drug-resistant and drug-sensitive strains in a single patient, or even several drug-resistant strains with discrete drug resistance-conferring mutations has been described in clinical isolates(<xref ref-type="bibr" rid="c18">18</xref>–<xref ref-type="bibr" rid="c20">20</xref>). Warren et al. found that the occurrence of mixed infections reached 19 % of the examined patients in South Africa by using a PCR-based strain classification method(<xref ref-type="bibr" rid="c21">21</xref>). Mixed infections can result from i) simultaneously or sequentially acquired infections by different strains or ii) genomic evolution of a strain under mutagenic pressure within the host (termed microevolution) and consequent coexistence of several populations. Accordingly, the emergence of genetically encoded resistance may either be due to microevolution or to the spreading of already existing variants from polyclonal infections under drug pressure. The difference between these two underlying mechanisms for the emergence of drug resistance is highly relevant to the treatment of TB. The investigation of stress induced mutagenesis in <italic>Mycobacteria</italic> are based on fluctuation assays(<xref ref-type="bibr" rid="c22">22</xref>),(<xref ref-type="bibr" rid="c23">23</xref>) besides several indirect evidence from descriptive studies(<xref ref-type="bibr" rid="c24">24</xref>–<xref ref-type="bibr" rid="c28">28</xref>). Some studies demonstrate the simultaneous presence of several subpopulations within the same host which they interpret as an indication of being prone to microevolution(<xref ref-type="bibr" rid="c19">19</xref>, <xref ref-type="bibr" rid="c29">29</xref>). It is also possible that certain strains have intrinsically higher mutability. For example, the lineage 2 strains of the Beijing genotype were shown to exhibit a higher mutation rate(<xref ref-type="bibr" rid="c30">30</xref>). On the other hand, others found stable <italic>M. tuberculosis</italic> genomes with no or only few emerging genomic changes over prolonged periods of treatment(<xref ref-type="bibr" rid="c26">26</xref>). Genotyping has enabled researchers to describe cases of co-infection by ≥2 different strains (mixed infection) or coexistence of clonal variants of the same strain(<xref ref-type="bibr" rid="c29">29</xref>, <xref ref-type="bibr" rid="c31">31</xref>, <xref ref-type="bibr" rid="c32">32</xref>). Introducing whole genome sequencing into this field still leaves the distinction between mixed infections with multiple similar strains and strains arisen by microevolution elusive. Depending on the elapsed time between two sample collections, the stepwise acquisition of mutations might be missed and the observed diversity may reflect concurrently existing subclones rather than newly emerged mutations(<xref ref-type="bibr" rid="c27">27</xref>). In addition, a single sputum sample usually does not represent the whole genomic diversity of the infection(<xref ref-type="bibr" rid="c16">16</xref>, <xref ref-type="bibr" rid="c31">31</xref>). Cell culturing can also lead to additional artefacts(<xref ref-type="bibr" rid="c33">33</xref>, <xref ref-type="bibr" rid="c34">34</xref>). The lack of standardized reporting of genome sequencing analyses also limits our ability to draw conclusions on within-host microevolution(<xref ref-type="bibr" rid="c27">27</xref>). Therefore, although several factors such as drug pressure and disease severity have been suggested to drive within-host microevolution and diversity(<xref ref-type="bibr" rid="c35">35</xref>, <xref ref-type="bibr" rid="c36">36</xref>) and it is now accepted that the <italic>M. tuberculosis</italic> population within individual patients can be heterogeneous, we could not find any unequivocal proof for explaining the mechanism of emergence of the observed genomic diversity which gives rise to drug resistance.</p>
<p>Therefore, to advance our knowledge on the effect of antibiotics on mycobacterial mutability, we conducted experiments under controlled laboratory conditions. We used <italic>Mycobacterium smegmatis</italic> (<italic>M. smegmatis</italic>) for our investigations. This non-pathogenic relative of the medically relevant <italic>Mycobacterium</italic> species shares most DNA metabolic pathways with the medically relevant strains. Davis and Forse compared the sequences of proteins involved in base excision repair and nucleotide excision repair pathways in <italic>E. coli</italic> and their homologs in <italic>M. smegmatis</italic> and <italic>M. tuberculosis</italic> and found that there is a high degree of conservation between the DNA repair enzymes in <italic>M. smegmatis</italic> and <italic>M. tuberculosis</italic>(<xref ref-type="bibr" rid="c37">37</xref>, <xref ref-type="bibr" rid="c38">38</xref>). Bioinformatic analyses of completely sequenced mycobacterial genomes including <italic>M. tuberculosis</italic>(<xref ref-type="bibr" rid="c39">39</xref>), <italic>M. leprae</italic>(<xref ref-type="bibr" rid="c40">40</xref>), <italic>M. bovis</italic>(<xref ref-type="bibr" rid="c41">41</xref>, <xref ref-type="bibr" rid="c42">42</xref>), <italic>M. avium, M. paratuberculosis</italic>, and <italic>M. smegmatis</italic>(<xref ref-type="bibr" rid="c43">43</xref>) also demonstrated through the comparison of genes participating in many of the DNA repair/recombination pathways that the basic strategy used to repair DNA lesions is conserved(<xref ref-type="bibr" rid="c44">44</xref>, <xref ref-type="bibr" rid="c45">45</xref>). Durbach et.al, investigated mycobacterial SOS response and showed that the <italic>M. tuberculosis, M. smegmatis</italic> and <italic>M. leprae</italic> LexA proteins are functionally conserved at the level of DNA binding(<xref ref-type="bibr" rid="c46">46</xref>). In our earlier paper, we also compared the enzymes of thymidylate biosynthesis in <italic>M. tuberculosis</italic> and <italic>M. smegmatis</italic> and found high conservation (<xref ref-type="bibr" rid="c47">47</xref>). Considering <italic>M. smegmatis</italic> is non-pathogenic and fast-growing, it provides an attainable model to obtain information on genomic changes under drug pressure in <italic>M. tuberculosis</italic>.</p>
<p>We systematically investigated the effects of currently used TB drugs on genome stability, on tolerance/ resistance acquisition, on the activation of the DNA repair system, and on the cellular dNTP pool. We focused particularly on drugs used in the standard treatment of drug-susceptible TB, comprising isoniazid (INH), rifampicin (RIF), ethambutol (EMB), and pyrazinamide (PZA), the so-called first-line antibiotics(<xref ref-type="bibr" rid="c48">48</xref>). We also used a second-line antibiotic, ciprofloxacin (CIP). We found that following exposure to these antibiotics, the activation of DNA repair pathways maintains genomic integrity, while non-genetic factors convey quick adaptation for the stress conditions. Notably, even with prolonged antibiotic exposure exceeding 360 bacterial generations, we observed no significant increase in the mutation rate, suggesting the absence of <italic>de novo</italic> adaptive mutagenesis.</p>
</sec>
<sec id="s2">
<label>2.</label><title>Material and methods</title>
<sec id="s2a">
<label>2.1.</label><title>Bacterial strains, media and growth conditions</title>
<p><italic>M. smegmatis</italic> mc<sup>2</sup>155 (<xref ref-type="bibr" rid="c49">49</xref>) strains were grown in Lemco broth (5 g/l Lab-Lemco, 5 g/l NaCl, 10 g/l Bacto pepcone, 0.05 % Tween-80) or on solid Lemco plates (6.25 g/l Lab-Lemco, 6.25 g/l NaCl, 12.5 g/l Bacto pepcone, 18.75 g/l Bacto agar).</p>
</sec>
<sec id="s2b">
<label>2.2</label><title>Optimization of stress treatments conditions</title>
<p>The optimal concentrations of drugs were searched for by using serial dilutions of the compounds on a logarithmic scale and by monitoring the number of colonies forming units (CFU) or the optical density (OD) at 600 nm on plates and in liquid cultures, respectively (Figure S1). We also monitored cell morphology in response to drug treatment. For further experiments, sublethal concentrations of drugs were used to obtain adequate quantity of research material (DNA, RNA, dNTP) for downstream analysis while the effect of the treatment was clearly indicated by a decrease of viability or change in cell size and morphology. The concentrations of applied drugs and stress conditions are compiled in <xref rid="tbl1" ref-type="table">Table 1</xref>.</p>
<table-wrap id="tbl1" orientation="portrait" position="float">
<label>Table 1</label>
<caption><title>Summary of the applied drug treatments and their phenotypic consequences</title></caption>
<graphic xlink:href="581394v2_tbl1.tif" mimetype="image" mime-subtype="tiff"/>
</table-wrap>
</sec>
<sec id="s2c">
<label>2.3.</label><title>Stress treatment of liquid cultures</title>
<p>Cells were grown in 100 ml liquid culture until an OD (600) = 0.1±0.02 was reached, then the appropriate quantity of drug (<xref rid="tbl1" ref-type="table">Table 1</xref>) was added to half of the cultures. The other half of the same culture was used as a control. We conducted the treatments for 8 hours. The cultures were then centrifuged (20 min, 3220 g, 4°C) and the resulting pellets were used for downstream analysis. The total CFUs were determined for each culture. The generation time after the treatments was calculated using the formula:
<disp-formula>
<graphic xlink:href="581394v2_ueqn1.gif" mimetype="image" mime-subtype="gif"/>
</disp-formula>
where T<sub>d</sub> is the generation time, t is the time interval between measurements, and N<sub>t</sub> and N<sub>0</sub> are the final and initial population size, respectively.</p>
</sec>
<sec id="s2d">
<label>2.4.</label><title>Microscopic analysis of cell morphology upon treatments</title>
<p>For morphological studies, 200-200 µl stress-treated and control cells were retrieved before RNA or dNTP extraction and washed with PBS containing 0.1% Triton X-100. The cells were then fixed in 4% PFA dissolved in PBS for 30 min at 37°C. Cells were stained with 10 µg/ml DAPI for 30 min at 37°C, then streaked onto microscopy slides covered with 0.1% low melting agarose (Sigma). Imaging was done using phase-contrast and fluorescent modes on a Leica DM IL LED (Leica) microscope. The cell size and volume were quantified using the automated recognition of the BacStalk software (<ext-link ext-link-type="uri" xlink:href="https://drescherlab.org/data/bacstalk/">https://drescherlab.org/data/bacstalk/</ext-link>)(<xref ref-type="bibr" rid="c50">50</xref>). The cell volume distribution diagram was prepared using OriginPro 2018 (OriginLab Corporation, Northampton, MA, USA.). The sample size, calculated means and standard deviations are compiled in Table S1.</p>
</sec>
<sec id="s2e">
<label>2.5.</label><title>Mutation accumulation (MA) experiments</title>
<p>Sixteen independent <italic>M. smegmatis</italic> mc<sup>2</sup> 155 MA lines were initiated from a single colony for every treatment. The ancestor cell colony was generated by streaking a new single colony from plate to plate 5 times before the beginning of the treatments to ensure a single common ancestor. Lemco agar medium was used for the mutation-accumulation line transfers. The specific stress treatment conditions are summarized in <xref rid="tbl1" ref-type="table">Table 1</xref>. All MA lines were incubated at 37°C. Every 3 days, a single isolated colony from each MA line was transferred by streaking to a new plate, ensuring that each line regularly passed through a single-cell bottleneck(<xref ref-type="bibr" rid="c51">51</xref>). Treatments were performed for 60 days, therefore each line passed through ∼360-480 cell divisions. We calculated 3 hours generation time for mock treatments and 4 hours for stress treated lines. Some of the mock treatments were performed for 120 days to ensure a presumably sufficient number of mutational events without stress treatment. Following the MA procedure, a single colony was transferred from all strains to a new plate without stress-treatment and grew for another 3 days for expansion. Frozen stocks of all lineages were prepared in 20% glycerol at −80°C.</p>
</sec>
<sec id="s2f">
<label>2.6.</label><title>DNA extraction</title>
<p>A single colony at the end of the MA experiment was inoculated into10 ml liquid culture from all lineages, was grown until OD<sub>600</sub> = 0.8-1.0, and harvested. For genomic DNA purification, 5 or 6 grown cultures of individual lineages from the same treatment with identical estimated cell number (based on OD measurements) were pooled before isolation. For cell disruption, the cells were resuspended in 1 ml of 10 mM Tris, pH 7.5, and 0.1 mm glass beads were added to a final volume of 1.5 ml. The cells were disrupted using a cell disruptor (Scientific Industries SI-DD38 Digital Disruptor Genie Cell Disruptor) in a cold room (at 4 °C). After centrifugation for 10 min at 3220 g, and at room temperature, DNA was extracted from the supernatant by phenol:chloroform:IAA (25:24:1) extraction followed by isopropanol precipitation. The quality and quantity of the extracted DNA was evaluated using UV photometry in a Nanodrop-2000 instrument and by agarose gel electrophoresis.</p>
</sec>
<sec id="s2g">
<label>2.7.</label><title>DNA library preparation and whole genome sequencing</title>
<p>The DNA library preparation and whole genome sequencing (WGS) was done at Novogene Ltd., Beijing, China. Sequencing was executed on Illumina 1.9 instruments with 600-basepair (bp) fragments as 2 × 150 bp paired end sequencing. An average read depth of 267 was achieved across all samples.</p>
</sec>
<sec id="s2h">
<label>2.8.</label><title>WGS analysis and mutation identification</title>
<p>Three parallel pooled samples were sequenced for every treatment, each contained 5 or 6 individually treated MA lineages that add up to a subtotal of 15-18 individual lineages. FastQC was used for analysing the quality of the raw reads. In case if adapters and low-quality bases (Phred score &lt; 20) were present in the samples, bases were trimmed with Trimmomatic(<xref ref-type="bibr" rid="c52">52</xref>). We mapped our paired end reads to <italic>M. smegmatis</italic> mc<sup>2</sup> 155 reference genome (GenBank accession number: NC_008596.1) by Bowtie2(<xref ref-type="bibr" rid="c53">53</xref>). PCR duplicates were removed with the use of Samblaster(<xref ref-type="bibr" rid="c54">54</xref>). We converted SAM files to BAM files, and sorted them with SAMtools(<xref ref-type="bibr" rid="c55">55</xref>).</p>
<p>Read groups were replaced by the Picard tool. Single nucleotide variations (SNVs), insertions and deletions were called from each alignment file using the HaplotypeCaller function of the Genome Analysis Toolkit(<xref ref-type="bibr" rid="c55">55</xref>). We analyzed the frequency of occurrence (% of all reads of a pooled sample) of each SNV, insertions and deletions (hits) with our in-house Python scripts and compared to the frequency of occurrence of the same hits in every other lineage. We considered mutations as spontaneously generated mutations only in case if no other lineages carried that variant in any depth and if hits reached at least 6% frequency of the reads at the corresponding position (theoretically, a spontaneously generated mutation in a pooled sample emerge with 20 % or 16.7 % frequency when 5 or 6 lineages are pooled, respectively, however, we allowed some variety when choosing 6 % as a lower limit and 39.9 % as an upper limit). Sequencing data are available at European Nucleotide Archive (ENA) with PRJEB71590 project number. Please note that we incorporated some of our additional sequencing data into the analysis, which is curated under the umbrella project at the ENA along with the present dataset.</p>
</sec>
<sec id="s2i">
<label>2.9.</label><title>RNA isolation and cDNA synthesis</title>
<p>For RNA extraction, cell pellets were resuspended in 2 ml RNA protect bacteria reagent (Quiagen; cat. no.:76506), incubated for 5 min at room temperature and centrifuged for 20 min at 3220 g and at 4 °C before storage at −80 °C. Total RNA extraction was performed with the Quiagen RNeasy Mini kit (cat. no.: 74524). To disrupt cells, 5 x 1 min of vortexing with glass beads in the manufacturer’s lysis buffer was performed followed by 1 min poses on ice. DNase digestion was performed on column with Quiagen DNase I (cat. no.: 79254), for 90 min at room temperature. For quantitative and qualitative RNA analysis, spectrometry by Nanodrop 2000 and non-denaturing 1 % agarose gel electrophoresis (50 min/100 V) were performed, respectively. cDNA synthesis was performed using the Applied Biosystems™ High-Capacity cDNA Reverse Transcription Kit with RNase Inhibitor (cat. no.: 4374967). 95-105 ng total RNA was used for each reaction.</p>
</sec>
<sec id="s2j">
<label>2.10.</label><title>Choosing the reference genes for the study</title>
<p>We tested SigA (MSMEG_2758), Ffh (MSMEG_2430), and ProC (MSMEG_0943) as possible reference gene candidates. SigA is a widely used reference gene in prokaryotes(<xref ref-type="bibr" rid="c56">56</xref>–<xref ref-type="bibr" rid="c58">58</xref>) Ffh and ProC genes are shown to be stably expressed in other pathogenes(<xref ref-type="bibr" rid="c59">59</xref>). Using GeNorm(<xref ref-type="bibr" rid="c60">60</xref>, <xref ref-type="bibr" rid="c61">61</xref>) analysis, SigA and Ffh proved to be stably expressed in our experimental system (Figure S2).</p>
</sec>
<sec id="s2k">
<label>2.11.</label><title>Gene expression quantification</title>
<p>qPCR measurements were performed on a Bio-Rad CFX96 Touch™ Real-Time PCR Detection System. Primers were designed using IDT DNA oligo customizer (<ext-link ext-link-type="uri" xlink:href="https://eu.idtdna.com/">https://eu.idtdna.com/</ext-link>), and were produced by Sigma Aldrich (for sequences, see Table S2). The qPCR reaction mixtures contained 7-7 nmoles of forward and reverse primers, 0.25 µl of the cDNA, Bioline Mytaq PCR premix (cat. no.: 25046), and VWR EvaGreen (cat. no.: #31000) in a total reaction volume of 10 µl. The thermal profile was as follows: 95 °C/10 min, 50x (95 °C/10 s; 62 °C/10 s; 72 °C/10 s). Melting curves were registered between 55 °C and 95 °C with an increment of 0.5 °C (Figure S3). The applied primers and their measured efficiencies are compiled in Table S2. The qPCR data were analyzed using the Bio-Rad CFX Maestro software and numerically shown in Table S3. Non-reverse transcribed controls and no-template controls were used to account for any irrelevant DNA contamination. 3 technical, and 3 biological replicates were used for all measurement. All raw data can be found in the Supplementary ZIP file.</p>
</sec>
<sec id="s2l">
<label>2.12.</label><title>dNTP extraction</title>
<p>dNTP extraction and measurement were performed according to Szabo et al.(<xref ref-type="bibr" rid="c62">62</xref>). Briefly, the cell pellets were extracted in precooled 0.5 ml 60% methanol overnight at −20°C. After 5 minutes boiling at 95°C, the cell debris was removed by centrifugation (20 min, 13 400 g, 4°C). The methanolic supernatant containing the soluble dNTP fraction was vacuum-dried (Eppendorf) at 45°C. Extracted dNTPs were dissolved in 50 μl nuclease-free water and stored at −20°C until use.</p>
</sec>
<sec id="s2m">
<label>2.13.</label><title>Determination of the cellular dNTP pool size</title>
<p>Determination of the dNTP pool size in each extract was as follows: 10 pmol template oligo (Sigma), 10 pmol probe (IDT) and 10 pmol NDP1 primer (Sigma) (see sequences in Table S4) was present per 25 μl reaction. The concentration of each non-specific dNTP was kept at 100 μM. VWR® TEMPase Hot Start DNA Polymerase (VWR) was used at 0.9 unit / reaction in the presence of 2.5 mM MgCl<sub>2</sub>. To record calibration curves, the reaction was supplied with 0–12 pmol specific dNTP. Fluorescence was recorded at every 13 seconds in a Bio-Rad CFX96 Touch™ Real-Time PCR Detection System or in a QuantStudio 1 qPCR instrument. The thermal profile was as follows: 95°C 15 min, (60°C 13 s) × 260 cycle for dATP measurement, and 95°C 15 min, (55°C 13 s) × 260 cycle for dTTP, dCTP and dGTP measurements. Results were analyzed using the nucleoTIDY software (<ext-link ext-link-type="uri" xlink:href="http://nucleotidy.enzim.ttk.mta.hu/">http://nucleotidy.enzim.ttk.mta.hu/</ext-link>)(<xref ref-type="bibr" rid="c62">62</xref>). Results were given in molar concentrations for better comparison. To this end, cell volumes were calculated using the BacStalk software based on microscopic images for every treatment. Besides the graphical presentation of the result, numerical data can be found in Table S5.</p>
</sec>
<sec id="s2n">
<label>2.14.</label><title>Tolerance assay</title>
<p>We used a modified version of fluctuation assays(<xref ref-type="bibr" rid="c63">63</xref>) for the estimation of the rate of emergence of resistant cells upon preincubation with a sublethal dose of CIP. An initial 100 ml culture was grown to OD = 0.4-0.5, was centrifuged for 30 min at 800 g and at 4 °C, then resuspended in 5 ml Lemco. 100 μL from this stock solution was streaked and cultured on normal Bacto Agar plate, and Bacto Agar containing 0.3 μg/mL CIP at a standardized fashion. Parallel plates were incubated for 4, 24, 48, 72, and 96 hours at 37 °C. Colonies were washed off the plate with 6 mL Lemco broth by incubation for 30 mins on a rocking shaker. Then CFU was determined on selective (containing 0.5 μg/mL CIP), and non-selective Bacto agar plates. Tolerance rates were calculated using the following formula:
<disp-formula>
<graphic xlink:href="581394v2_ueqn2.gif" mimetype="image" mime-subtype="gif"/>
</disp-formula></p>
<p>t: time of preincubation</p>
<p><inline-formula><inline-graphic xlink:href="581394v2_inline1.gif" mimetype="image" mime-subtype="gif"/></inline-formula>: Number of colonies on non-selecting agar plates at reference time point</p>
<p><inline-formula><inline-graphic xlink:href="581394v2_inline2.gif" mimetype="image" mime-subtype="gif"/></inline-formula>: Number of colonies on non-selecting agar plates at t hours</p>
<p><inline-formula><inline-graphic xlink:href="581394v2_inline3.gif" mimetype="image" mime-subtype="gif"/></inline-formula> : Number of colonies on plates containing 0.5 μg/ml CIP at reference time point</p>
<p><inline-formula><inline-graphic xlink:href="581394v2_inline4.gif" mimetype="image" mime-subtype="gif"/></inline-formula>: Number of colonies on plates containing 0.5 μg/ml CIP at t hours</p>
<p><inline-formula><inline-graphic xlink:href="581394v2_inline5.gif" mimetype="image" mime-subtype="gif"/></inline-formula>− <inline-formula><inline-graphic xlink:href="581394v2_inline6.gif" mimetype="image" mime-subtype="gif"/></inline-formula>: Number of newly emerging resistant colonies</p>
<p><inline-formula><inline-graphic xlink:href="581394v2_inline7.gif" mimetype="image" mime-subtype="gif"/></inline-formula>−<inline-formula><inline-graphic xlink:href="581394v2_inline8.gif" mimetype="image" mime-subtype="gif"/></inline-formula>: Number of growing colonies</p>
<p><inline-formula><inline-graphic xlink:href="581394v2_inline9.gif" mimetype="image" mime-subtype="gif"/></inline-formula>: Generation time during pre-treatment</p>
</sec>
<sec id="s2o">
<label>2.15.</label><title>Statistics</title>
<p>We used an initial F-test to test the equality of variances of the tested groups. If the F-test hypothesis was accepted (p &lt; 0.05), we used the two-way homoscedastic t-probe; if rejected, we used the two-way Welch’s t-probe to assess differences at a significance level p &lt; 0.05 in each case. F- and t-statistics were counted for the ΔCt values(<xref ref-type="bibr" rid="c64">64</xref>) of the qPCR results and for the concentrations normalized to the cell volume in case of the dNTP measurements.</p>
</sec>
</sec>
<sec id="s3">
<label>3.</label><title>Results</title>
<sec id="s3a">
<label>3.1.</label><title>Adapting stress conditions and assessing their impact on cell viability and morphology</title>
<p>For an efficient TB treatment, first-line antituberculotics are used in combination in the clinics (isoniazid – INH; ethambuthol – EMB; rifampicine – RIF; pyrazinamide - PZA)(<xref ref-type="bibr" rid="c36">36</xref>). To model this drug pressure in our study, we also combined the four first-line drugs in addition to applying them one by one. We added a second line antibiotic, ciprofloxacin (CIP). MitomycinC (MMC) and ultraviolet (UV) irradiation were used as positive controls for direct DNA damage(<xref ref-type="bibr" rid="c65">65</xref>, <xref ref-type="bibr" rid="c66">66</xref>). We optimized the drug concentration for all applied treatments. First- and second line antituberculosis drugs were used in sublethal concentrations to convey a phenotypic effect while allowing to keep an adequate number of cells for the downstream measurements (Figure S1 and <xref rid="tbl1" ref-type="table">Table 1</xref>). In the first-line combination treatment, a 10-fold reduced concentration of each separately adjusted drug had to be applied to allow the survival of enough cells for the analyses (<xref rid="tbl1" ref-type="table">Table 1</xref>). The fact that a lower dose of antibiotics applied in combination resulted in higher CFU reduction indicates the synergistic effect of the first-line antibiotics on <italic>M. smegmatis</italic> growth inhibition (<xref rid="tbl1" ref-type="table">Table 1</xref>). After an eight-hour drug treatment, we determined the viable cell count by CFU measurements (<xref rid="tbl1" ref-type="table">Table 1</xref>). The bacteriostatic drugs INH and EMB caused moderate CFU decrease compared to the control (<xref rid="tbl1" ref-type="table">Table 1</xref>, Figure S1) consistent with their mechanism of action(<xref ref-type="bibr" rid="c67">67</xref>). To quantify the phenotypic effect of the applied drug treatments on the cells, we analyzed the cellular dimensions using microscopy (<xref rid="fig1" ref-type="fig">Figure 1</xref> and <xref rid="tbl1" ref-type="table">Table 1</xref>). The observed morphological changes provided evidence of the treatments’ effectiveness (<xref rid="fig1" ref-type="fig">Figure 1</xref> and <xref rid="tbl1" ref-type="table">Table 1</xref>). Specifically, following RIF, CIP, and MMC treatments, we observed cells elongating by more than twofold, whereas INH and EMB treatments led to a reduction in cell length (<xref rid="fig1" ref-type="fig">Figure 1</xref>, <xref rid="tbl1" ref-type="table">Table 1</xref>). The combination treatment did not affect the cell size.</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1</label>
<caption><p>Cell volume distribution of <italic>M. smegmatis</italic> treated with different drugs. Various drug treatments are color-coded. Numerical values along with the used and obtained statistical parameters are shown in Table S1.</p></caption>
<graphic xlink:href="581394v2_fig1.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>We also assayed the clinically relevant drug pyrazinamide (PZA). However, <italic>M. smegmatis</italic> was reported to exhibit an intrinsic resistance to PZA(<xref ref-type="bibr" rid="c68">68</xref>). Indeed, PZA treatment on its own even at high concentration in acidic conditions had no effect on cell viability in our experiments (Figure S1). Therefore, we only used it in the combination treatment.</p>
</sec>
<sec id="s3b">
<label>3.2.</label><title>The genome of <italic>M. smegmatis</italic> remains stable even under antibiotic pressure</title>
<p>16 independent <italic>M. smegmatis</italic> MC<sup>2</sup> 155 lineages for each stress treatment condition and 56 lineages for the mock control were initiated and cultured from single colonies. The stress treated lines and some of the mock lines were maintained through 60 days on agar plates. The rest of the mock lines were maintained through 120 days on agar plates. Drug treated lineages were maintained for shorter times as more mutations were expected to arise under drug pressure. We estimated an average generation time of 4h for stress treated cells based on our experiments done in liquid media with CFU counting at the beginning and at the end of the treatments (for the calculation, see Materials and Methods). Therefore, bacteria produced ∼360-400 generations during the 60 days treatment. The untreated control (mock) cells were assessed to have an approximate generation time of 3 hours, resulting in around 480 or 960 cell divisions over 60 or 120 experimental days, respectively. Following the treatment on solid plates, we expanded each lineage in a liquid culture without drug pressure and isolated genomic DNA. All lineages were sent to WGS to reveal the mutational events induced by the drug treatments. We set conditions so to obtain at least 30-60x sequencing depth for all positions per independent lineage. The ancestor colony was also sent for sequencing to detect already existing variations compared to the reference genome. According to the WGS results, our <italic>M. smegmatis</italic> ancestor strain carried 151 various mutations compared to the <italic>M. smegmatis</italic> reference genome deposited in the GenBank. These mutation hits were also found in all treated and untreated lineages and were omitted from further calculations as these are specific variations of our laboratory strain. We also removed those mutation hits that were found in any other independent lineage at the same position in any depth.</p>
<p>After careful cross-checking of the sequencing data, a surprisingly low number of new mutations was detected. We found that a maximum of 1 mutation per lineage occurred during the 60-day drug treatments. Also, a maximum of 1 mutation per lineage was detected during the 60- or 120-day mock treatment (16 newly generated mutations for 56 lineages). Therefore, we calculated an approximately 5 x 10<sup>-11</sup> mutation rate for our untreated <italic>M. smegmatis mc<sup>2</sup>155</italic> strain. To our great surprise, the mutation rate of all treated lineages was in the same range (2.5-20 x 10<sup>-11</sup>) except for the UV treatment used for positive control (<xref rid="fig2" ref-type="fig">Figure 2</xref> and <xref rid="tbl2" ref-type="table">Table 2</xref>).</p>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2</label>
<caption><p>Mutation rates of wild-type <italic>M. smegmatis mc<sup>2</sup>155</italic> strains under antibiotic pressure and DNA damaging stress in the mutation accumulation assay. Error bars represent standard deviations.</p></caption>
<graphic xlink:href="581394v2_fig2.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<table-wrap id="tbl2" orientation="portrait" position="float">
<label>Table 2</label>
<caption><title>Mutation rates measured in the wild-type <italic>M. smegmatis mc<sup>2</sup>155</italic> at the conclusion of the mutation accumulation assay</title></caption>
<graphic xlink:href="581394v2_tbl2.tif" mimetype="image" mime-subtype="tiff"/>
</table-wrap>
<p>We analyzed each mutation except for those obtained following the UV treatment and found no sign of adaptive changes. The excel file containing the positions of the mutations in the genome and their identifiable consequences at the transcriptional or protein level is provided in the archive deposited with the article.</p>
</sec>
<sec id="s3c">
<label>3.3.</label><title>The DNA repair system shows a treatment-specific activation pattern</title>
<p>To reveal the reason for detecting so few newly generated mutations under antibiotic pressure, we investigated whether the DNA repair pathways and other elements of the stress response potentially involved(<xref ref-type="bibr" rid="c69">69</xref>) were activated under drug pressure. The mycobacterial DNA repair system is highly redundant, many of its enzymes have overlapping functions(<xref ref-type="bibr" rid="c45">45</xref>, <xref ref-type="bibr" rid="c70">70</xref>, <xref ref-type="bibr" rid="c71">71</xref>). Although canonical mismatch repair proteins are thought to be missing, a recently described protein, NucS is encoded with similar function(<xref ref-type="bibr" rid="c72">72</xref>). We investigated the expression pattern of DNA repair genes in all known DNA repair pathways in <italic>Mycobacteria</italic> including NucS using RT-qPCR, a method suitable to accurately show changes in transcript levels. The measured relative expression levels are shown in <xref rid="fig3" ref-type="fig">Figure 3</xref> and Table S3.</p>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3</label>
<caption><p>Changes in the expression of DNA repair genes upon stress treatments. Gene expression changes are normalized to the mock treated control using the SigA and Ffh reference genes. Upregulation is interpreted as fold change; downregulation is interpreted as −1/ (fold change). * p&lt;0.1; ** p&lt;0.05.</p></caption>
<graphic xlink:href="581394v2_fig3.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
<p>Treatments with the two antibiotics affecting cell wall synthesis (INH and EMB) show similar patterns in the expression levels with an overall downregulation of DNA repair genes. On the contrary, CIP and MMC, drugs directly targeting DNA integrity induce a pattern marked by a moderate to strong overexpression of nucleotide excision and double-strand break (DSB) repair genes, respectively (<xref rid="fig3" ref-type="fig">Figure 3</xref>). DNA polymerases DinB2 and DnaE2 involved in these DNA repair pathways are also strongly overexpressed (<xref rid="fig3" ref-type="fig">Figure 3</xref>). RIF, the DNA-dependent RNA polymerase inhibitor does not seem to induce any change in the expression pattern of the investigated genes except for the Ahp peroxiredoxin (<xref rid="fig3" ref-type="fig">Figure 3</xref>). As a result of the 1<sup>st</sup> line combination (COMBO) treatment, 14 out of 38 investigated genes are significantly (p &lt;0.05) upregulated. More than 4-fold upregulation can be measured for 5 members of the base excision repair pathway. In addition, the MutT2 dNTP pool sanitization enzyme and the error-prone DNA polymerases are also strongly upregulated. (<xref rid="fig3" ref-type="fig">Figure 3</xref>). Interestingly, however, the DSB repair enzymes are exempt from this overall upregulation tendency (<xref rid="fig3" ref-type="fig">Figure 3</xref>). The strongest measured effect of all is the 17-fold expression increase of the KatG1 peroxidase (<xref rid="fig3" ref-type="fig">Figure 3</xref>). When the 1<sup>st</sup> line antibiotics were used one by one, significant expression change could only be observed upon the INH treatment (4/38 genes) and in the opposite direction (downregulation).</p>
</sec>
<sec id="s3d">
<label>3.4.</label><title>All but the combination treatment alters the size and balance of dNTP pools</title>
<p>It was shown that dNTP pools are crucial for genome maintenance and proper DNA synthesis(<xref ref-type="bibr" rid="c73">73</xref>–<xref ref-type="bibr" rid="c76">76</xref>). Imbalanced or altered levels of dNTPs could cause increased rate of DNA lesions and therefore, may play a role in the development of drug resistance. Therefore, we measured cellular dNTP concentrations and ratios in function of the applied drug treatments using a fluorescent detection based method optimized in our lab(<xref ref-type="bibr" rid="c62">62</xref>). We used MMC treatment as a positive control as this is a generally used positive control for DNA damage(<xref ref-type="bibr" rid="c66">66</xref>, <xref ref-type="bibr" rid="c77">77</xref>). To calculate cellular concentrations, we used the previously determined cellular volumes (<xref rid="fig1" ref-type="fig">Figure 1</xref>). Interestingly, we found altered dNTP pools upon most treatments (<xref rid="fig4" ref-type="fig">Figure 4</xref> and Tables S4-5). The CIP treatment resulted in the most remarkable differences in particular for dATP and dTTP concentrations which increased ∼7-fold accompanied by a decrease in the dGTP concentration (<xref rid="fig4" ref-type="fig">Figure 4E</xref>). RIF, CIP and MMC treatments promoted an increase in the dCTP and dTTP pools (<xref rid="fig4" ref-type="fig">Figure 4D-F</xref>), while INH and EMB coincided with a decreased concentration of these nucleotides (<xref rid="fig4" ref-type="fig">Figure 4B-C</xref>). In the case of the combination treatment, the levels of these two nucleotides did not change (<xref rid="fig4" ref-type="fig">Figure 4A</xref>). The dGTP pool decreased in both absolute and relative values in all treatments (<xref rid="fig4" ref-type="fig">Figure 4A-G</xref>). Another major observation is that a larger overall dNTP pool size coincides with a larger cell size and vice versa (<xref rid="fig4" ref-type="fig">Figure 4H</xref>).</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4</label>
<caption><p>First line antituberculotic treatments and DNA damaging agents alter dNTP concentrations in the cell. A-F) Cellular dNTP concentrations of drug treated <italic>M. smegmatis</italic>. dNTP quantities were measured in cellular extracts and normalized to the average cell volume in each treatment to obtain the shown concentrations. Each drug treatment and dNTP quantitation included its own control to account for potential fluctuations in growth and experimental conditions. Note the different scales on the Y axis. Data bars represent the averages of three biological replicates each carried out in three technical replicates; error bars represent SE. The p-values of the t-tests calculated for the measured differences are shown in Table S5. G) dNTP pool compositions of drug treated bacteria. The large error bars in the control data arise from the combination of individual controls measured for each treatment. H) The observed levels of dNTP concentration in the cells (all four dNTPs combined) show a comparable trend to changes in cell size under different treatments. All data is compared to the mock treatment.</p></caption>
<graphic xlink:href="581394v2_fig4.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
<sec id="s3e">
<label>3.5.</label><title>Stress induced drug tolerance is developed upon pretreatment with sublethal concentration of CIP</title>
<p>To compare the result of the mutation accumulation experiment to a phenotype-based drug resistance assay, we chose the fluctuation assay generally used in the literature(<xref ref-type="bibr" rid="c63">63</xref>). Mutation rates in these tests are calculated based on the difference in the number of CFU values between cultures grown in regular broth compared to those in selecting broths. These assays assume that the resistance exclusively occurs upon one mutation event. Since the genetic background of a drug-tolerant colony is not confirmed, this presumption potentially leads to a significant misinterpretation of the actual mutation rate. For clarity, we refer to the mutation rate estimations in our phenotype-based resistance assay as tolerance rate. For valid comparison with the results of our mutation accumulation assay, we installed similar experimental conditions. Specifically, culturing was done on agar plates, the applied drug concentrations were in the same range as used during the mutation accumulation process, then colonies were washed off and CFU counting plates were streaked from the resuspended bacteria (<xref rid="fig5" ref-type="fig">Figure 5A</xref>). We found that the estimated rate of emergence of the tolerance for CIP is three orders of magnitude higher than the mutation rate calculated based on WGS (10<sup>-7</sup> vs. 10<sup>-10</sup>, cf. <xref rid="tbl2" ref-type="table">Table 2</xref>). Furthermore, following a 20-96 h exposure to a sublethal 0.3 μg/ml dose of CIP, a phenotypic tolerance appears in a significant portion of the cells to an otherwise lethal 0.5 μg/ml dose (<xref rid="fig5" ref-type="fig">Figure 5B</xref>). The tolerant cell population increased with the length of the preincubation time before reaching a maximum (<xref rid="fig5" ref-type="fig">Figure 5B</xref>).</p>
<fig id="fig5" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5</label>
<caption><p>Phenotypic CIP tolerance assay. A) Scheme of the fluctuation test used in the study. B) Development of phenotypic resistance to a selecting CIP concentration following preincubation with a sublethal CIP concentration for various time periods. Data bars represent the averages of three biological replicates each carried out in three technical replicates; error bars represent SE.</p></caption>
<graphic xlink:href="581394v2_fig5.tif" mimetype="image" mime-subtype="tiff"/>
</fig>
</sec>
</sec>
<sec id="s4">
<label>4.</label><title>Discussion</title>
<p>One of the reasons that TB is still a great medical challenge is the frequent incidence of resistant cases. The main goal of our research was to get a better understanding of the molecular mechanisms of drug resistance development in mycobacteria. We started from the hypothesis that the long-term exposure to first-line antitubercular drugs increases mutability.</p>
<sec id="s4a">
<label>4.1</label><title>Drug resistance in <italic>M. smegmatis</italic> does not arise from increased mutation rates under antibiotic pressure</title>
<p>Measured and estimated mycobacterial mutation rates in the earlier literature are in the order of 10<sup>-10</sup> /bp/generation(<xref ref-type="bibr" rid="c78">78</xref>),(<xref ref-type="bibr" rid="c79">79</xref>),(<xref ref-type="bibr" rid="c30">30</xref>),(<xref ref-type="bibr" rid="c80">80</xref>). This low constitutive mutation rate by itself does not explain the biological diversity observed in clinical isolates(<xref ref-type="bibr" rid="c24">24</xref>). This diversity might result from an elevated mutagenesis rate or the accumulation of different strains from the environment. We conducted a modelling study in <italic>M. smegmatis</italic> to investigate whether exposure to first-line antibiotics generates such biological diversity and if yes, by what molecular mechanism. We measured the appearance of drug-induced mutations in the genome in a mutation accumulation assay using whole genome sequencing. We also examined the rapid occurrence of phenotypic tolerance. The difference between the results of the phenotypic and the mutation accumulation studies was surprisingly large. Even without a pretreatment, a tolerance rate of 10<sup>-7</sup> /generation could be observed for CIP (consistently with literature data from fluctuation assays(<xref ref-type="bibr" rid="c81">81</xref>, <xref ref-type="bibr" rid="c82">82</xref>)), while in the mutation accumulation assay, the number of mutations remained under 10<sup>-10</sup> /generation. In fact, the mutation rate increase was only significant in the case of the UV treatment serving as positive control for the experiments (<xref rid="fig2" ref-type="fig">Figure 2</xref>). Previous studies claiming mutation rate increase upon antibiotics treatment assessed mutation rates using fluctuation assays and no direct evidence of the change in the genetic material was shown(<xref ref-type="bibr" rid="c23">23</xref>, <xref ref-type="bibr" rid="c83">83</xref>). Our findings imply that the emergence of drug resistance in this study is attributed to phenotypic factors. Phenotypic changes upon antibiotics treatment have widely been investigated(<xref ref-type="bibr" rid="c84">84</xref>) including potentially bistability(<xref ref-type="bibr" rid="c85">85</xref>) and/or the upregulation of efflux pumps(<xref ref-type="bibr" rid="c86">86</xref>, <xref ref-type="bibr" rid="c87">87</xref>). It is noteworthy that spontaneous mutagenesis is easily induced through UV treatment. Considering that mycobacterial species spread through air droplets, it is conceivable that the exposure of these droplets to environmental UV radiation could potentially lead to the generation of new mutations.</p>
</sec>
<sec id="s4b">
<label>4.2</label><title>The combination treatment with frontline drugs induces an overall upregulation in the DNA repair pathways aimed at eliminating misincorporations</title>
<p>The intracellular lifestyle of the TB pathogen implies that these bacteria must face various stress conditions and damaging agents including reactive oxygen and nitrogen species inside macrophages. Therefore, stress-induced transcriptional changes in <italic>Mycobacteria</italic> have been studied on genome-wide scales(<xref ref-type="bibr" rid="c84">84</xref>),(<xref ref-type="bibr" rid="c88">88</xref>) and one study found a specific activation of the DNA repair system in response to CIP similar to ours(<xref ref-type="bibr" rid="c66">66</xref>). Although <italic>M. smegmatis</italic> is not an intracellular pathogen, it shares the DNA repair pathways with <italic>M. tuberculosis</italic> and is often used to study how mycobacteria deal with DNA lesions(<xref ref-type="bibr" rid="c45">45</xref>). We focused our investigation on stress-induced transcriptional changes that may account for the protection of genomic integrity under the drug pressure of first-line antituberculotic drugs.</p>
<p>Redox potential change is a well-known and common phenotypic response to INH in <italic>Mycobacteria</italic>(<xref ref-type="bibr" rid="c89">89</xref>). The downregulation of KatG1 and Nei2 in response to our INH treatment (<xref rid="fig3" ref-type="fig">Figure 3</xref>) is in line with this and might indicate a reduced cellular redox potential. KatG1 is the enzyme that activates the prodrug INH(<xref ref-type="bibr" rid="c89">89</xref>), therefore, the downregulation of this enzyme decreases the active drug concentration and increases the tolerance of <italic>M. smegmatis</italic> against INH. In the case of the first-line combination treatment, however, KatG1 was highly upregulated, indicating high ROS levels in the cell(<xref ref-type="bibr" rid="c90">90</xref>). High ROS levels are known to cause damage to nucleobases and the nucleotide pool is a major effector of oxidative stress-induced genotoxic damage(<xref ref-type="bibr" rid="c91">91</xref>). In line with this, we observed upregulation in dNTP pool sanitation, base- and nucleotide-repair pathways which play crucial roles in preventing and repairing DNA damage caused by oxidative stress. The observed synergistic effect clearly results from the combination of first-line drugs, as we did not observe this effect when applying the drugs individually. The observed upregulation of the relevant DNA repair enzymes might account for the low mutation rate even under drug pressure. Notably, error-prone polymerases DinB2 and DnaE2 exhibited significant upregulation without inducing a mutator phenotype. This indicates that error-prone and error-free repair mechanisms are coactivated, predominantly resulting in error-free repairs.</p>
</sec>
<sec id="s4c">
<label>4.3</label><title>dNTP pool alterations induced by frontline drugs neutralize each other in the combination treatment resulting normal DNA precursor pools</title>
<p>The building blocks of DNA constitute a critical component within the molecular aspects of mutability. It has been shown that increased or imbalanced dNTP pools induce mutagenesis in prokaryotes(<xref ref-type="bibr" rid="c92">92</xref>) and eukaryotes<sup>86</sup>. To assess the impact of drug treatment on dNTP pools and its correlation with genome stability, we quantified the concentrations of dNTPs in cell extracts obtained from the drug-treated cells. When treating the cells with frontline drugs EMB and INH individually, the observed reductions in dNTP pool sizes and cell size (as illustrated in <xref rid="fig4" ref-type="fig">Figure 4E</xref>) aligned well with the concurrent downregulated transcript levels (<xref rid="fig3" ref-type="fig">Figure 3</xref>). Resting states of bacteria have also been characterized with a decrease in cell size and dATP levels(<xref ref-type="bibr" rid="c93">93</xref>, <xref ref-type="bibr" rid="c94">94</xref>). These observations reflect the bacteriostatic effect of these drugs causing metabolic processes entering a dormant state, accompanied by the downregulation of enzymes involved in dNTP synthesis. This contrasts with the monotreatment with RIF, in which case dNTP concentrations, mainly dCTP and dTTP were elevated correlating with increased cell length. The combined treatment yielded the least significant alteration as if the opposite effects of the frontline drugs cancelled each other out. An elevation in the dNTP pools during cytostatic or cytotoxic treatment is more unexpected and suggests elevated DNA repair activity. This observation, particularly in the case of CIP treatment, aligns with the substantial increase in the expression of DNA repair synthesis genes, as depicted in <xref rid="fig3" ref-type="fig">Figure 3</xref>. Among all administered treatments, only the CIP treatment led to a notable dNTP imbalance and a substantial overall rise in dNTP pools, due to elevated levels of dTTP and dATP. This coincides with the largest changes in the expression of DNA repair genes, particularly those associated with the SOS response and homologous recombination (<xref rid="fig3" ref-type="fig">Figure 3</xref>). Interestingly, the dGTP level decreased with all drug treatments. This finding suggests that dGTP may play a role in a general stress response. It is noteworthy that not all dNTP imbalances are created equal. Specifically, an excess of dGTP has been identified as a significant contributor to mutations(<xref ref-type="bibr" rid="c95">95</xref>, <xref ref-type="bibr" rid="c96">96</xref>). It must be noted that in these (and most) organisms dGTP is the least abundant among dNTPs. However, in mycobacteria, a unique scenario exists where dGTP is the most abundant dNTP species(<xref ref-type="bibr" rid="c97">97</xref>) and mycobacterial genomes are characterized by a high GC content(<xref ref-type="bibr" rid="c98">98</xref>). A reduction in dGTP levels in this context may contribute to minimizing DNA lesions by enhancing proofreading efficiency.</p>
</sec>
<sec id="s4d">
<label>4.4</label><title>Our results do not support drug resistance acquisition through drug-induced microevolution</title>
<p>Our hypothesis that systematic antibiotics treatment induces mutation rate increase in <italic>M. smegmatis</italic> failed, as we did not observe any significant impact of antibiotics on mutability in laboratory conditions. Only in the case of CIP treatment, a second-line TB drug known for directly inducing DNA damage, could we detect a slightly elevated mutation rate. The treatment of <italic>M. smegmatis</italic> with the clinically used combination therapy drugs did not induce a mutator effect, quite the opposite. The observed activation of DNA repair processes likely mitigates mutation pressure, ensuring genome stability.</p>
<p>If there is no indication for <italic>a priori</italic> drug resistance, TB patients are treated with the combination therapy of first-line antituberculotics. In at least 17 % of the treatments, resistance to RIF or RIF+INH (called multidrug resistance) emerges(<xref ref-type="bibr" rid="c1">1</xref>). There are two models for the development of drug-resistant TB: acquired and transmitted drug resistance. The acquired drug resistance model suggests that resistance is developed within patients with active TB through microevolution(<xref ref-type="bibr" rid="c27">27</xref>). Several studies suggest examples for microevolution(<xref ref-type="bibr" rid="c28">28</xref>),(<xref ref-type="bibr" rid="c99">99</xref>) especially those involving the hypermutable <italic>Bejing Mtb</italic> lineage(<xref ref-type="bibr" rid="c100">100</xref>). However, it is crucial to note that distinguishing between acquired and transmitted resistance is not straightforward based solely on allele variants found in the sputum. In the transmitted resistance model, a patient accumulates a pool of <italic>Mycobacteria</italic> with different genotypes during latent infection. This population mix is essentially clonal, as <italic>M. tuberculosis</italic> strains possess a highly conserved core genome(<xref ref-type="bibr" rid="c14">14</xref>), but with several genetic allele variants having limited representation. The transition of the disease to an active phase, along with subsequent chemotherapy, leads to adaptive selection from the pre-existing pool of variants. The concept that certain TB cases involve mixed infections has been substantiated in clinical cases using phage typing and whole-genome sequencing(<xref ref-type="bibr" rid="c101">101</xref>, <xref ref-type="bibr" rid="c102">102</xref>). Transmissibility of resistant variants has been confirmed through strain specific PCR(<xref ref-type="bibr" rid="c103">103</xref>), and selective adaptation in a patient during chemotherapy has also been demonstrated (<xref ref-type="bibr" rid="c17">17</xref>). Furthermore, it has been shown that clonal complexity is reduced by culturing, leading to the underrecognition of polyclonal infections in culture-based diagnosis(<xref ref-type="bibr" rid="c104">104</xref>). The WHO estimates that a quarter of the world’s population is latently infected by <italic>M. tuberculosis</italic>, accumulating different TB strains throughout their lives(<xref ref-type="bibr" rid="c105">105</xref>). Consequently, patients may harbor high heterogeneity, facilitating the spread and fixation of a genetic variant that holds some advantage in specific environmental conditions.</p>
<p>We acknowledge the limitations of using <italic>M. smegmatis</italic> as a model for the intracellular pathogen <italic>M. tuberculosis</italic>, which is associated with complex pathology. Nevertheless, given the conserved molecular mechanisms of genome maintenance in <italic>Mycobacteria</italic>, we can conclude that the mycobacterial genome is not prone to microevolution upon prolonged exposure to the antibiotics employed in our study and the clinics.</p>
</sec>
</sec>
<sec id="s5">
<label>5.</label><title>Conclusion</title>
<p>We showed that prolonged exposure to clinically used antibiotics did not lead to <italic>de novo</italic> adaptive mutagenesis in <italic>M. smegmatis</italic> under laboratory conditions. The activation of DNA repair pathways preserves genomic integrity, while non-genetic factors convey quick adaptation for stress conditions.</p>
<p>Supplementary Data are available at NAR online.</p>
</sec>
<sec id="d1e1423" sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material id="d1e1514">
<label>Supplemental material</label>
<media xlink:href="supplements/581394_file02.pdf"/>
</supplementary-material>
</sec>
</body>
<back>
<sec id="s6">
<label>6.</label><title>Data availability</title>
<p>The data underlying this article are available in the Figshare repository (using a private link shared with the Editor for now); DOI: 10.6084/m9.figshare.25028186 (reserved DOI until acceptation).</p>
</sec>
<ack>
<label>7.</label>
<title>Acknowledgement</title>
<p>We would like to express our gratitude for the assistance provided by Ádám Póti in the analysis of the WGS data.</p>
</ack>
<sec id="s7">
<label>8.</label><title>Funding</title>
<p>This work was supported by the National Office for Research and Technology, Hungary [grant number OTKA-K115993 and OTKA-K138318 to J.T., OTKA-PD128254 to R.H.]. Funding for open access charge: National Office for Research and Technology, Hungary</p>
</sec>
<ref-list>
<label>9.</label>
<title>References</title>
<ref id="c1"><label>1.</label><mixed-citation publication-type="other"><source>World Health Organization Global tuberculosis report</source> <year>2023</year>.</mixed-citation></ref>
<ref id="c2"><label>2.</label><mixed-citation publication-type="journal"><string-name><surname>Ehrt</surname>, <given-names>S.</given-names></string-name> and <string-name><surname>Schnappinger</surname>, <given-names>D</given-names></string-name>. (<year>2009</year>) <article-title>Mycobacterial survival strategies in the phagosome: Defence against host stresses</article-title>. <source>Cell. Microbiol</source>., <volume>11</volume>, <fpage>1170</fpage>–<lpage>1178</lpage>.</mixed-citation></ref>
<ref id="c3"><label>3.</label><mixed-citation publication-type="journal"><string-name><surname>Jankute</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Cox</surname>, <given-names>J.A.G.</given-names></string-name>, <string-name><surname>Harrison</surname>, <given-names>J.</given-names></string-name> and <string-name><surname>Besra</surname>, <given-names>G.S</given-names></string-name>. (<year>2015</year>) <article-title>Assembly of the Mycobacterial Cell Wall</article-title>. <source>Annu. Rev. Microbiol</source>., <volume>69</volume>, <fpage>405</fpage>–<lpage>423</lpage>.</mixed-citation></ref>
<ref id="c4"><label>4.</label><mixed-citation publication-type="journal"><string-name><surname>Hett</surname>, <given-names>E.C.</given-names></string-name> and <string-name><surname>Rubin</surname>, <given-names>E.J</given-names></string-name>. (<year>2008</year>) <article-title>Bacterial Growth and Cell Division: a Mycobacterial Perspective</article-title>. <source>Microbiol. Mol. Biol. Rev</source>., <volume>72</volume>, <fpage>126</fpage>–<lpage>156</lpage>.</mixed-citation></ref>
<ref id="c5"><label>5.</label><mixed-citation publication-type="journal"><string-name><surname>Stallings</surname>, <given-names>C.L.</given-names></string-name> and <string-name><surname>Glickman</surname>, <given-names>M.S</given-names></string-name>. (<year>2010</year>) <article-title>Is Mycobacterium tuberculosis stressed out? A critical assessment of the genetic evidence</article-title>. <source>Microbes Infect</source>., <volume>12</volume>, <fpage>1091</fpage>–<lpage>1101</lpage>.</mixed-citation></ref>
<ref id="c6"><label>6.</label><mixed-citation publication-type="journal"><string-name><surname>Miggiano</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Morrone</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Rossi</surname>, <given-names>F.</given-names></string-name> and <string-name><surname>Rizzi</surname>, <given-names>M</given-names></string-name>. (<year>2020</year>) <article-title>Targeting genome integrity in mycobacterium tuberculosis: From nucleotide synthesis to DNA replication and repair</article-title>. <source>Molecules</source>, <volume>25</volume>.</mixed-citation></ref>
    <ref id="c7"><label>7.</label><mixed-citation publication-type="journal"><string-name><surname>Balaban</surname>, <given-names>N.Q.</given-names></string-name>, <string-name><surname>Helaine</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Lewis</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Ackermann</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Aldridge</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Andersson</surname>, <given-names>D.I.</given-names></string-name>, <string-name><surname>Brynildsen</surname>, <given-names>M.P.</given-names></string-name>, <string-name><surname>Bumann</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Camilli</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Collins</surname>, <given-names>J.J.</given-names></string-name>, <etal>et al.</etal> <article-title>Definitions and guidelines for research on antibiotic persistence</article-title>. <source>Nat Rev Microbiol</source> <pub-id pub-id-type="doi">10.1038/s41579-019-0196-3</pub-id>.</mixed-citation></ref>
<ref id="c8"><label>8.</label><mixed-citation publication-type="journal"><string-name><surname>Walter</surname>, <given-names>N.D.</given-names></string-name>, <string-name><surname>Dolganov</surname>, <given-names>G.M.</given-names></string-name>, <string-name><surname>Garcia</surname>, <given-names>B.J.</given-names></string-name>, <string-name><surname>Worodria</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Andama</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Musisi</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Ayakaka</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Van</surname>, <given-names>T.T.</given-names></string-name>, <string-name><surname>Voskuil</surname>, <given-names>M.I.</given-names></string-name>, <string-name><surname>De Jong</surname>, <given-names>B.C.</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>) <article-title>Transcriptional Adaptation of Drug-tolerant Mycobacterium tuberculosis During Treatment of Human Tuberculosis</article-title>. <source>J. Infect. Dis</source>., <volume>212</volume>, <fpage>990</fpage>.</mixed-citation></ref>
<ref id="c9"><label>9.</label><mixed-citation publication-type="journal"><string-name><surname>Boshoff</surname>, <given-names>H.I.M.</given-names></string-name>, <string-name><surname>Myers</surname>, <given-names>T.G.</given-names></string-name>, <string-name><surname>Copp</surname>, <given-names>B.R.</given-names></string-name>, <string-name><surname>McNeil</surname>, <given-names>M.R.</given-names></string-name>, <string-name><surname>Wilson</surname>, <given-names>M.A.</given-names></string-name> and <string-name><surname>Barry</surname>, <given-names>C.E</given-names></string-name>. (<year>2004</year>) <article-title>The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. Novel insights into drug mechanisms of action</article-title>. <source>J. Biol. Chem</source>., <volume>279</volume>, <fpage>40174</fpage>–<lpage>40184</lpage>.</mixed-citation></ref>
<ref id="c10"><label>10.</label><mixed-citation publication-type="journal"><string-name><surname>Goossens</surname>, <given-names>S.N.</given-names></string-name>, <string-name><surname>Sampson</surname>, <given-names>S.L.</given-names></string-name> and <string-name><surname>Van Rie</surname>, <given-names>A.</given-names></string-name> (<year>2021</year>) <article-title>Mechanisms of drug-induced tolerance in mycobacterium tuberculosis</article-title>. <source>Clin. Microbiol. Rev</source>., <volume>34</volume>, <fpage>1</fpage>–<lpage>21</lpage>.</mixed-citation></ref>
<ref id="c11"><label>11.</label><mixed-citation publication-type="journal"><string-name><surname>Louw</surname>, <given-names>G.E.</given-names></string-name>, <string-name><surname>Warren</surname>, <given-names>R.M.</given-names></string-name>, <string-name><surname>Gey Van Pittius</surname>, <given-names>N.C.</given-names></string-name>, <string-name><surname>Leon</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Jimenez</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Hernandez-Pando</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>McEvoy</surname>, <given-names>C.R.E.</given-names></string-name>, <string-name><surname>Grobbelaar</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Murray</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Van Helden</surname>, <given-names>P.D.</given-names></string-name>, <etal>et al.</etal> (<year>2011</year>) <article-title>Rifampicin Reduces Susceptibility to Ofloxacin in Rifampicin-resistant Mycobacterium tuberculosis through Efflux</article-title>. <source>Am. J. Respir. Crit. Care Med</source>., <volume>184</volume>, <fpage>269</fpage>.</mixed-citation></ref>
<ref id="c12"><label>12.</label><mixed-citation publication-type="journal"><string-name><surname>Wiuff</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Zappala</surname>, <given-names>R.M.</given-names></string-name>, <string-name><surname>Regoes</surname>, <given-names>R.R.</given-names></string-name>, <string-name><surname>Garner</surname>, <given-names>K.N.</given-names></string-name>, <string-name><surname>Baquero</surname>, <given-names>F.</given-names></string-name> and <string-name><surname>Levin</surname>, <given-names>B.R</given-names></string-name>. (<year>2005</year>) <article-title>Phenotypic Tolerance: Antibiotic Enrichment of Noninherited Resistance in Bacterial Populations</article-title>. <source>Antimicrob. Agents Chemother</source>., <volume>49</volume>, <fpage>1483</fpage>.</mixed-citation></ref>
<ref id="c13"><label>13.</label><mixed-citation publication-type="journal"><string-name><surname>Dookie</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Rambaran</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Padayatchi</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Mahomed</surname>, <given-names>S.</given-names></string-name> and <string-name><surname>Naidoo</surname>, <given-names>K</given-names></string-name>. (<year>2018</year>) <article-title>Evolution of drug resistance in Mycobacterium tuberculosis: A review on the molecular determinants of resistance and implications for personalized care</article-title>. <source>J. Antimicrob. Chemother</source>., <volume>73</volume>, <fpage>1138</fpage>–<lpage>1151</lpage>.</mixed-citation></ref>
<ref id="c14"><label>14.</label><mixed-citation publication-type="journal"><string-name><surname>Gray</surname>, <given-names>T.A.</given-names></string-name> and <string-name><surname>Derbyshire</surname>, <given-names>K.M</given-names></string-name>. (<year>2018</year>) <article-title>Blending genomes: distributive conjugal transfer in mycobacteria, a sexier form of HGT</article-title>. <source>Mol. Microbiol</source>., <volume>108</volume>, <fpage>601</fpage>–<lpage>613</lpage>.</mixed-citation></ref>
<ref id="c15"><label>15.</label><mixed-citation publication-type="journal"><string-name><surname>Madacki</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Orgeur</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Fiol</surname>, <given-names>G.M.</given-names></string-name>, <string-name><surname>Frigui</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Ma</surname>, <given-names>L.</given-names></string-name> and <string-name><surname>Brosch</surname>, <given-names>R</given-names></string-name>. (<year>2021</year>) <article-title>Esx-1-independent horizontal gene transfer by mycobacterium tuberculosis complex strains</article-title>. <source>MBio</source>, <volume>12</volume>.</mixed-citation></ref>
<ref id="c16"><label>16.</label><mixed-citation publication-type="journal"><string-name><surname>Liu</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Via</surname>, <given-names>L.E.</given-names></string-name>, <string-name><surname>Luo</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Liang</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Wu</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Shen</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Wei</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Ruan</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Yuan</surname>, <given-names>X.</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>) <article-title>Within patient microevolution of Mycobacterium tuberculosis correlates with heterogeneous responses to treatment OPEN</article-title>. <source>Nat. Publ. Gr</source>., <volume>450003</volume>.</mixed-citation></ref>
<ref id="c17"><label>17.</label><mixed-citation publication-type="journal"><string-name><surname>Hingley-Wilson</surname>, <given-names>S.M.</given-names></string-name>, <string-name><surname>Casey</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Connell</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Bremang</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Evans</surname>, <given-names>J.T.</given-names></string-name>, <string-name><surname>Hawkey</surname>, <given-names>P.M.</given-names></string-name>, <string-name><surname>Smith</surname>, <given-names>G.E.</given-names></string-name>, <string-name><surname>Jepson</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Philip</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Kon</surname>, <given-names>O.M.</given-names></string-name>, <etal>et al.</etal> (<year>2013</year>) <article-title>Undetected multidrug-resistant tuberculosis amplified by first-line therapy in mixed infection</article-title>. <source>Emerg. Infect. Dis</source>., <volume>19</volume>, <fpage>1138</fpage>–<lpage>1141</lpage>.</mixed-citation></ref>
<ref id="c18"><label>18.</label><mixed-citation publication-type="journal"><string-name><surname>Asare-Baah</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Séraphin</surname>, <given-names>M.N.</given-names></string-name>, <string-name><surname>Salmon</surname>, <given-names>L.A.T.</given-names></string-name> and <string-name><surname>Lauzardo</surname>, <given-names>M</given-names></string-name>. (<year>2021</year>) <article-title>Effect of mixed strain infections on clinical and epidemiological features of tuberculosis in Florida</article-title>. <source>Infect. Genet. Evol</source>., <volume>87</volume>, <fpage>104659</fpage>.</mixed-citation></ref>
<ref id="c19"><label>19.</label><mixed-citation publication-type="journal"><string-name><surname>Pérez-Lago</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Rodríguez Borlado</surname>, <given-names>A.I.</given-names></string-name>, <string-name><surname>Comas</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Herranz</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Ruiz-Serrano</surname>, <given-names>M.J.</given-names></string-name>, <string-name><surname>Bouza</surname>, <given-names>E.</given-names></string-name> and <string-name><surname>García-de-Viedma</surname>, <given-names>D</given-names></string-name>. (<year>2016</year>) <article-title>Subtle genotypic changes can be observed soon after diagnosis in Mycobacterium tuberculosis infection</article-title>. <source>Int. J. Med. Microbiol</source>., <volume>306</volume>, <fpage>401</fpage>–<lpage>405</lpage>.</mixed-citation></ref>
<ref id="c20"><label>20.</label><mixed-citation publication-type="journal"><string-name><surname>Lozano</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Lanza</surname>, <given-names>V.F.</given-names></string-name>, <string-name><surname>Suárez-González</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Herranz</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Sola-Campoy</surname>, <given-names>P.J.</given-names></string-name>, <string-name><surname>Rodríguez-Grande</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Buenestado-Serrano</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Jesús Ruiz-Serrano</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Tudó</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Alcaide</surname>, <given-names>F.</given-names></string-name>, <etal>et al.</etal> (<year>2021</year>) <article-title>Detection of Minority Variants and Mixed Infections in Mycobacterium tuberculosis by Direct Whole-Genome Sequencing on Noncultured Specimens Using a Specific-DNA Capture Strategy</article-title>. <source>mSphere</source>, <volume>6</volume>.</mixed-citation></ref>
<ref id="c21"><label>21.</label><mixed-citation publication-type="journal"><string-name><surname>Warren</surname>, <given-names>R.M.</given-names></string-name>, <string-name><surname>Victor</surname>, <given-names>T.C.</given-names></string-name>, <string-name><surname>Streicher</surname>, <given-names>E.M.</given-names></string-name>, <string-name><surname>Richardson</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Beyers</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Gey Van Pittius</surname>, <given-names>N.C.</given-names></string-name> and <string-name><surname>Van Helden</surname>, <given-names>P.D.</given-names></string-name> (<year>2004</year>) <article-title>Patients with Active Tuberculosis often Have Different Strains in the Same Sputum Specimen</article-title>. <source>Am. J. Respir. Crit. Care Med</source>., <volume>169</volume>, <fpage>610</fpage>–<lpage>614</lpage>.</mixed-citation></ref>
<ref id="c22"><label>22.</label><mixed-citation publication-type="journal"><string-name><surname>Ford</surname>, <given-names>C.B.</given-names></string-name>, <string-name><surname>Shah</surname>, <given-names>R.R.</given-names></string-name>, <string-name><surname>Maeda</surname>, <given-names>M.K.</given-names></string-name>, <string-name><surname>Gagneux</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Murray</surname>, <given-names>M.B.</given-names></string-name>, <string-name><surname>Cohen</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Johnston</surname>, <given-names>J.C.</given-names></string-name>, <string-name><surname>Gardy</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Lipsitch</surname>, <given-names>M.</given-names></string-name> and <string-name><surname>Fortune</surname>, <given-names>S.M</given-names></string-name>. (<year>2013</year>) <article-title>Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis</article-title>. <source>Nat. Genet</source>., <volume>45</volume>, <fpage>784</fpage>–<lpage>90</lpage>.</mixed-citation></ref>
<ref id="c23"><label>23.</label><mixed-citation publication-type="journal"><string-name><surname>Gillespie</surname>, <given-names>S.H.</given-names></string-name>, <string-name><surname>Basu</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Dickens</surname>, <given-names>A.L.</given-names></string-name>, <string-name><surname>O’Sullivan</surname>, <given-names>D.M.</given-names></string-name> and <string-name><surname>McHugh</surname>, <given-names>T.D</given-names></string-name>. (<year>2005</year>) <article-title>Effect of subinhibitory concentrations of ciprofloxacin on Mycobacterium fortuitum mutation rates</article-title>. <source>J. Antimicrob. Chemother</source>., <volume>56</volume>, <fpage>344</fpage>–<lpage>348</lpage>.</mixed-citation></ref>
<ref id="c24"><label>24.</label><mixed-citation publication-type="journal"><string-name><surname>Sun</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Luo</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Yang</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Dong</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Li</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Zhu</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Zheng</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Tian</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Barry</surname>, <given-names>C.E.</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>) <article-title>Dynamic population changes in Mycobacterium tuberculosis during acquisition and fixation of drug resistance in patients</article-title>. <source>J. Infect. Dis</source>., <volume>206</volume>, <fpage>1724</fpage>–<lpage>33</lpage>.</mixed-citation></ref>
<ref id="c25"><label>25.</label><mixed-citation publication-type="journal"><string-name><surname>Espinosa</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Norman</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Mokrousov</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>García De Viedma</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Navarro</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Pérez-Lago</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Herranz</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Sierra</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Comas</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Sicilia</surname>, <given-names>J.</given-names></string-name>, <etal>et al.</etal> (<year>2017</year>) <article-title>In-Depth Characterization and Functional Analysis of Clonal Variants in a Mycobacterium tuberculosis Strain Prone to Microevolution</article-title>. <source>Front. Microbiol.</source> | <ext-link ext-link-type="uri" xlink:href="http://www.frontiersin.org">www.frontiersin.org</ext-link>, <volume>8</volume>, <fpage>694</fpage>.</mixed-citation></ref>
<ref id="c26"><label>26.</label><mixed-citation publication-type="journal"><string-name><surname>Herranz</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Pole</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Ozere</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Chiner-Oms</surname>, <given-names>Á.</given-names></string-name>, <string-name><surname>Martínez-Lirola</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Pérez-García</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Gijón</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Serrano</surname>, <given-names>M.J.R.</given-names></string-name>, <string-name><surname>Romero</surname>, <given-names>L.C.</given-names></string-name>, <string-name><surname>Cuevas</surname>, <given-names>O.</given-names></string-name>, <etal>et al.</etal> (<year>2018</year>) <article-title>Mycobacterium tuberculosis acquires limited genetic diversity in prolonged infections, reactivations and transmissions involving multiple hosts</article-title>. <source>Front. Microbiol</source>., <volume>8</volume>, <fpage>2661</fpage>.</mixed-citation></ref>
<ref id="c27"><label>27.</label><mixed-citation publication-type="journal"><string-name><surname>Ley</surname>, <given-names>S.D.</given-names></string-name>, <string-name><surname>de Vos</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Van Rie</surname>, <given-names>A.</given-names></string-name> and <string-name><surname>Warren</surname>, <given-names>R.M.</given-names></string-name> (<year>2019</year>) <article-title>Deciphering Within-Host Microevolution of Mycobacterium tuberculosis through Whole-Genome Sequencing: the Phenotypic Impact and Way Forward</article-title>. <source>Microbiol. Mol. Biol. Rev</source>., <volume>83</volume>.</mixed-citation></ref>
<ref id="c28"><label>28.</label><mixed-citation publication-type="journal"><string-name><surname>Al-Hajoj</surname>, <given-names>S.A.M.</given-names></string-name>, <string-name><surname>Akkerman</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Parwati</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Al-Gamdi</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Rahim</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Van Soolingen</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Van Ingen</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Supply</surname>, <given-names>P.</given-names></string-name> and <string-name><surname>Van Der Zanden</surname>, <given-names>A.G.M.</given-names></string-name> (<year>2010</year>) <article-title>Microevolution of Mycobacterium tuberculosis in a tuberculosis patient</article-title>. <source>J. Clin. Microbiol</source>., <volume>48</volume>, <fpage>3813</fpage>–<lpage>3816</lpage>.</mixed-citation></ref>
<ref id="c29"><label>29.</label><mixed-citation publication-type="journal"><string-name><surname>Navarro</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Herranz</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Pérez-Lago</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Lirola</surname>, <given-names>M.M.</given-names></string-name>, <string-name><surname>Ruiz-Serrano</surname>, <given-names>M.J.</given-names></string-name>, <string-name><surname>Bouza</surname>, <given-names>E.</given-names></string-name> and <string-name><surname>De Viedma</surname>, <given-names>D.G.</given-names></string-name> (<year>2011</year>) <article-title>Systematic Survey of Clonal Complexity in Tuberculosis at a Populational Level and Detailed Characterization of the Isolates Involved</article-title>. <source>J. Clin. Microbiol</source>., <volume>49</volume>, <fpage>4131</fpage>.</mixed-citation></ref>
<ref id="c30"><label>30.</label><mixed-citation publication-type="other"><string-name><surname>Ford</surname>, <given-names>C.B.</given-names></string-name>, <string-name><surname>Lin</surname>, <given-names>P.L.</given-names></string-name>, <string-name><surname>Chase</surname>, <given-names>M.R.</given-names></string-name>, <string-name><surname>Shah</surname>, <given-names>R.R.</given-names></string-name>, <string-name><surname>Iartchouk</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Galagan</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Mohaideen</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Ioerger</surname>, <given-names>T.R.</given-names></string-name>, <string-name><surname>Sacchettini</surname>, <given-names>J.C.</given-names></string-name>, <string-name><surname>Lipsitch</surname>, <given-names>M.</given-names></string-name>, <etal>et al.</etal> (<year>2011</year>) <source>Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection</source>. <volume>43</volume>.</mixed-citation></ref>
<ref id="c31"><label>31.</label><mixed-citation publication-type="journal"><string-name><surname>Shamputa</surname>, <given-names>I.C.</given-names></string-name>, <string-name><surname>Jugheli</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Sadradze</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Willery</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Portaels</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Supply</surname>, <given-names>P.</given-names></string-name> and <string-name><surname>Rigouts</surname>, <given-names>L</given-names></string-name>. (<year>2006</year>) <article-title>Mixed infection and clonal representativeness of a single sputum sample in tuberculosis patients from a penitentiary hospital in Georgia</article-title>. <source>Respir. Res</source>., <volume>7</volume>.</mixed-citation></ref>
<ref id="c32"><label>32.</label><mixed-citation publication-type="journal"><string-name><surname>Muwonge</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Kankya</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Olea-Popelka</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Biffa</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Ssengooba</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Berit</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Skjerve</surname>, <given-names>E.</given-names></string-name> and <string-name><surname>Johansen</surname>, <given-names>T.B</given-names></string-name>. (<year>2013</year>) <article-title>Molecular investigation of multiple strain infections in patients with tuberculosis in Mubende district, Uganda</article-title>. <source>Infect. Genet. Evol</source>., <volume>17</volume>, <fpage>16</fpage>–<lpage>22</lpage>.</mixed-citation></ref>
<ref id="c33"><label>33.</label><mixed-citation publication-type="journal"><string-name><surname>Doyle</surname>, <given-names>R.M.</given-names></string-name>, <string-name><surname>Burgess</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Williams</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Gorton</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Booth</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Brown</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Bryant</surname>, <given-names>J.M.</given-names></string-name>, <string-name><surname>Chan</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Creer</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Holdstock</surname>, <given-names>J.</given-names></string-name>, <etal>et al.</etal> (<year>2018</year>) <article-title>Direct whole-genome sequencing of sputum accurately identifies drug-resistant mycobacterium tuberculosis faster than MGIT culture sequencing</article-title>. <source>J. Clin. Microbiol</source>., <volume>56</volume>, <fpage>666</fpage>–<lpage>684</lpage>.</mixed-citation></ref>
<ref id="c34"><label>34.</label><mixed-citation publication-type="journal"><string-name><surname>Metcalfe</surname>, <given-names>J.Z.</given-names></string-name>, <string-name><surname>Streicher</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Theron</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Colman</surname>, <given-names>R.E.</given-names></string-name>, <string-name><surname>Penaloza</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Allender</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Lemmer</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Warren</surname>, <given-names>R.M.</given-names></string-name> and <string-name><surname>Engelthaler</surname>, <given-names>D.M</given-names></string-name>. (<year>2017</year>) <article-title>Mycobacterium tuberculosis subculture results in loss of potentially clinically relevant heteroresistance</article-title>. <source>Antimicrob. Agents Chemother</source>., <volume>61</volume>.</mixed-citation></ref>
<ref id="c35"><label>35.</label><mixed-citation publication-type="journal"><string-name><surname>O’Neill</surname>, <given-names>M.B.</given-names></string-name>, <string-name><surname>Mortimer</surname>, <given-names>T.D.</given-names></string-name> and <string-name><surname>Pepperell</surname>, <given-names>C.S</given-names></string-name>. (<year>2015</year>) <article-title>Diversity of Mycobacterium tuberculosis across Evolutionary Scales</article-title>. <source>PLOS Pathog</source>., <volume>11</volume>, <fpage>e1005257</fpage>.</mixed-citation></ref>
<ref id="c36"><label>36.</label><mixed-citation publication-type="journal"><string-name><surname>Trauner</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Via</surname>, <given-names>L.E.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Ruan</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Liang</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Shi</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Liang</surname>, <given-names>R.</given-names></string-name>, <etal>et al.</etal> (<year>2017</year>) <article-title>The within-host population dynamics of Mycobacterium tuberculosis vary with treatment efficacy</article-title>. <source>Genome Biol</source>., <volume>18</volume>, <fpage>1</fpage>–<lpage>17</lpage>.</mixed-citation></ref>
<ref id="c37"><label>37.</label><mixed-citation publication-type="journal"><string-name><surname>Kurthkoti</surname>, <given-names>K.</given-names></string-name> and <string-name><surname>Varshney</surname>, <given-names>U</given-names></string-name>. (<year>2012</year>) <article-title>Distinct mechanisms of DNA repair in mycobacteria and their implications in attenuation of the pathogen growth</article-title>. <source>Mech. Ageing Dev</source>., <volume>133</volume>, <fpage>138</fpage>–<lpage>46</lpage>.</mixed-citation></ref>
<ref id="c38"><label>38.</label><mixed-citation publication-type="other"><string-name><surname>Davis</surname>, <given-names>E.</given-names></string-name> and <string-name><surname>Forse</surname>, <given-names>L.</given-names></string-name> (<year>2009</year>) <article-title>DNA repair: key to survival?</article-title> <source>Mycobacterium Genomics Mol</source>. <italic>…</italic>.</mixed-citation></ref>
<ref id="c39"><label>39.</label><mixed-citation publication-type="journal"><string-name><surname>Camus</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Pryor</surname>, <given-names>M.J.</given-names></string-name>, <string-name><surname>Médigue</surname>, <given-names>C.</given-names></string-name> and <string-name><surname>Cole</surname>, <given-names>S.T</given-names></string-name>. (<year>2002</year>) <article-title>Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv</article-title>. <source>Microbiology</source>, <volume>148</volume>, <fpage>2967</fpage>–<lpage>2973</lpage>.</mixed-citation></ref>
<ref id="c40"><label>40.</label><mixed-citation publication-type="journal"><string-name><surname>Silva</surname>, <given-names>F.J.</given-names></string-name>, <string-name><surname>Santos-Garcia</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Zheng</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Zhang</surname>, <given-names>L.</given-names></string-name> and <string-name><surname>Han</surname>, <given-names>X.Y</given-names></string-name>. (<year>2022</year>) <article-title>Construction and Analysis of the Complete Genome Sequence of Leprosy Agent Mycobacterium lepromatosis</article-title>. <source>Microbiol. Spectr</source>., <volume>10</volume>, <fpage>1</fpage>–<lpage>17</lpage>.</mixed-citation></ref>
<ref id="c41"><label>41.</label><mixed-citation publication-type="journal"><string-name><surname>Garnier</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Eiglmeier</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Camus</surname>, <given-names>J.C.</given-names></string-name>, <string-name><surname>Medina</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Mansoor</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Pryor</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Duthoy</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Grondin</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Lacroix</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Monsempe</surname>, <given-names>C.</given-names></string-name>, <etal>et al.</etal> (<year>2003</year>) <article-title>The complete genome sequence of Mycobacterium bovis</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A</source>., <volume>100</volume>, <fpage>7877</fpage>–<lpage>7882</lpage>.</mixed-citation></ref>
<ref id="c42"><label>42.</label><mixed-citation publication-type="journal"><string-name><surname>Zimpel</surname>, <given-names>C.K.</given-names></string-name>, <string-name><surname>Brandão</surname>, <given-names>P.E.</given-names></string-name>, <string-name><surname>de Souza Filho</surname>, <given-names>A.F.</given-names></string-name>, <string-name><surname>de Souza</surname>, <given-names>R.F.</given-names></string-name>, <string-name><surname>Ikuta</surname>, <given-names>C.Y.</given-names></string-name>, <string-name><surname>Ferreira Neto</surname>, <given-names>J.S.</given-names></string-name>, <string-name><surname>Camargo</surname>, <given-names>N.C.S.</given-names></string-name>, <string-name><surname>Heinemann</surname>, <given-names>M.B.</given-names></string-name> and <string-name><surname>Guimarães</surname>, <given-names>A.M.S.</given-names></string-name> (<year>2017</year>) <article-title>Complete Genome Sequencing of Mycobacterium bovis SP38 and Comparative Genomics of Mycobacterium bovis and M. tuberculosis Strains</article-title>. <source>Front. Microbiol</source>., <volume>8</volume>, <fpage>1</fpage>–<lpage>14</lpage>.</mixed-citation></ref>
<ref id="c43"><label>43.</label><mixed-citation publication-type="other"><string-name><surname>Mohan</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Padiadpu</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Baloni</surname>, <given-names>P.</given-names></string-name> and <string-name><surname>Chandra</surname>, <given-names>N.</given-names></string-name> (<year>2015</year>) <article-title>Complete Genome Sequences of a Mycobacterium smegmatis Laboratory Strain (MC 2 155) and Isoniazid-Resistant (4XR1/R2) Mutant Strains</article-title>. <source>Genome Announc</source> <pub-id pub-id-type="doi">10.1128/genomeA.01520-14</pub-id>.</mixed-citation></ref>
<ref id="c44"><label>44.</label><mixed-citation publication-type="journal"><string-name><surname>Singh</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Patil</surname>, ^ <given-names>K</given-names></string-name> <string-name><surname>Neelakanteshwar</surname></string-name>, <string-name><surname>Jasbeer</surname></string-name>, ^, <string-name><surname>Khanduja</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Sanjay Kumar</surname>, ^ <given-names>P</given-names></string-name>, <string-name><surname>Williams</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Rossi</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Rizzi</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Davis</surname>, <given-names>E.O.</given-names></string-name> and <string-name><surname>Muniyappa</surname>, <given-names>K.</given-names></string-name> (<year>2010</year>) <article-title>Mycobacterium tuberculosis UvrD1 and UvrA Proteins Suppress DNA Strand Exchange Promoted by Cognate and Noncognate RecA Proteins †</article-title>. <source>Biochemistry</source>, <volume>49</volume>, <fpage>4872</fpage>–<lpage>4883</lpage>.</mixed-citation></ref>
<ref id="c45"><label>45.</label><mixed-citation publication-type="journal"><string-name><surname>Singh</surname>, <given-names>A.</given-names></string-name> (<year>2017</year>) <article-title>Guardians of the mycobacterial genome: A review on DNA repair systems in Mycobacterium tuberculosis</article-title>. <source>Microbiology</source> <volume>163</volume>, <fpage>1740</fpage>–<lpage>1758</lpage>.</mixed-citation></ref>
<ref id="c46"><label>46.</label><mixed-citation publication-type="journal"><string-name><surname>Durbach</surname>, <given-names>S.I.</given-names></string-name>, <string-name><surname>Andersen</surname>, <given-names>S.J.</given-names></string-name> and <string-name><surname>Mizrahi</surname>, <given-names>V</given-names></string-name>. (<year>1997</year>) <article-title>SOS induction in mycobacteria: Analysis of the DNA-binding activity of a LexA-like repressor and its role in DNA damage induction of the recA gene from Mycobacterium smegmatis</article-title>. <source>Mol. Microbiol</source>., <volume>26</volume>, <fpage>643</fpage>–<lpage>653</lpage>.</mixed-citation></ref>
<ref id="c47"><label>47.</label><mixed-citation publication-type="journal"><string-name><surname>Pecsi</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Hirmondo</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Brown</surname>, <given-names>A.C.</given-names></string-name>, <string-name><surname>Lopata</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Parish</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Vertessy</surname>, <given-names>B.G.</given-names></string-name> and <string-name><surname>Tóth</surname>, <given-names>J</given-names></string-name>. (<year>2012</year>) <article-title>The dutpase enzyme is essential in Mycobacterium smegmatis</article-title>. <source>PLoS One</source>, <volume>7</volume>, <fpage>e37461</fpage>.</mixed-citation></ref>
<ref id="c48"><label>48.</label><mixed-citation publication-type="journal"><string-name><surname>Grace</surname>, <given-names>A.G.</given-names></string-name>, <string-name><surname>Mittal</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Jain</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Tripathy</surname>, <given-names>J.P.</given-names></string-name>, <string-name><surname>Satyanarayana</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Tharyan</surname>, <given-names>P.</given-names></string-name> and <string-name><surname>Kirubakaran</surname>, <given-names>R</given-names></string-name>. (<year>2019</year>) <article-title>Shortened treatment regimens versus the standard regimen for drug-sensitive pulmonary tuberculosis</article-title>. <source>Cochrane Database Syst. Rev</source>., <volume>2019</volume>.</mixed-citation></ref>
<ref id="c49"><label>49.</label><mixed-citation publication-type="journal"><string-name><surname>Snapper</surname>, <given-names>S.B.</given-names></string-name>, <string-name><surname>Melton</surname>, <given-names>R.E.</given-names></string-name>, <string-name><surname>Mustafa</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Kieser</surname>, <given-names>T.</given-names></string-name> and Jr, W.R.J. (<year>1990</year>) <article-title>Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis</article-title>. <source>Mol. Microbiol</source>., <volume>4</volume>, <fpage>1911</fpage>–<lpage>1919</lpage>.</mixed-citation></ref>
<ref id="c50"><label>50.</label><mixed-citation publication-type="journal"><string-name><surname>Hartmann</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>van Teeseling</surname>, <given-names>M.C.F.</given-names></string-name>, <string-name><surname>Thanbichler</surname>, <given-names>M.</given-names></string-name> and <string-name><surname>Drescher</surname>, <given-names>K.</given-names></string-name> (<year>2020</year>) <article-title>BacStalk: A comprehensive and interactive image analysis software tool for bacterial cell biology</article-title>. <source>Mol. Microbiol</source>., <volume>114</volume>, <fpage>140</fpage>–<lpage>150</lpage>.</mixed-citation></ref>
<ref id="c51"><label>51.</label><mixed-citation publication-type="journal"><string-name><surname>Kibota</surname>, <given-names>T.T.</given-names></string-name> and <string-name><surname>Lynch</surname>, <given-names>M</given-names></string-name>. (<year>1996</year>) <article-title>Estimate of the genomic mutation rate deleterious to overall fitness in E. coli</article-title>. <source>Nature</source>, <volume>381</volume>, <fpage>694</fpage>–<lpage>696</lpage>.</mixed-citation></ref>
<ref id="c52"><label>52.</label><mixed-citation publication-type="journal"><string-name><surname>Bolger</surname>, <given-names>A.M.</given-names></string-name>, <string-name><surname>Lohse</surname>, <given-names>M.</given-names></string-name> and <string-name><surname>Usadel</surname>, <given-names>B</given-names></string-name>. (<year>2014</year>) <article-title>Trimmomatic: A flexible trimmer for Illumina sequence data</article-title>. <source>Bioinformatics</source>, <volume>30</volume>, <fpage>2114</fpage>–<lpage>2120</lpage>.</mixed-citation></ref>
<ref id="c53"><label>53.</label><mixed-citation publication-type="journal"><string-name><surname>Langmead</surname>, <given-names>B.</given-names></string-name> and <string-name><surname>Salzberg</surname>, <given-names>S.L</given-names></string-name>. (<year>2012</year>) <article-title>Fast gapped-read alignment with Bowtie 2</article-title>. <source>Nat. Methods</source>, <volume>9</volume>, <fpage>357</fpage>–<lpage>359</lpage>.</mixed-citation></ref>
<ref id="c54"><label>54.</label><mixed-citation publication-type="journal"><string-name><surname>Faust</surname>, <given-names>G.G.</given-names></string-name> and <string-name><surname>Hall</surname>, <given-names>I.M</given-names></string-name>. (<year>2014</year>) <article-title>SAMBLASTER: Fast duplicate marking and structural variant read extraction</article-title>. <source>Bioinformatics</source>, <volume>30</volume>, <fpage>2503</fpage>–<lpage>2505</lpage>.</mixed-citation></ref>
<ref id="c55"><label>55.</label><mixed-citation publication-type="journal"><string-name><surname>McKenna</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Hanna</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Banks</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Sivachenko</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Cibulskis</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Kernytsky</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Garimella</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Altshuler</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Gabriel</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Daly</surname>, <given-names>M.</given-names></string-name>, <etal>et al.</etal> (<year>2010</year>) <article-title>The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data</article-title>. <source>Genome Res</source>., <volume>20</volume>, <fpage>1297</fpage>–<lpage>1303</lpage>.</mixed-citation></ref>
<ref id="c56"><label>56.</label><mixed-citation publication-type="journal"><string-name><surname>Hirmondó</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Lopata</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Surányi</surname>, <given-names>É.V.</given-names></string-name>, <string-name><surname>Vértessy</surname> <given-names>G.</given-names></string-name>, <string-name><given-names>B.</given-names> <surname>and Tóth</surname></string-name>, J. (<year>2017</year>) <article-title>Differential control of dNTP biosynthesis and genome integrity maintenance by the dUTPase superfamily enzymes</article-title>. <source>Sci. Rep</source>., <volume>7</volume>.</mixed-citation></ref>
<ref id="c57"><label>57.</label><mixed-citation publication-type="journal"><string-name><surname>Milano</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Branzoni</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Canneva</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Profumo</surname>, <given-names>A.</given-names></string-name> and <string-name><surname>Riccardi</surname>, <given-names>G</given-names></string-name>. (<year>2004</year>) <article-title>The Mycobacterium tuberculosis Rv2358–furB operon is induced by zinc</article-title>. <source>Res. Microbiol</source>., <volume>155</volume>, <fpage>192</fpage>–<lpage>200</lpage>.</mixed-citation></ref>
<ref id="c58"><label>58.</label><mixed-citation publication-type="journal"><string-name><surname>Madikonda</surname>, <given-names>A.K.</given-names></string-name>, <string-name><surname>Shaikh</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Khanra</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Yakkala</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Yellaboina</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Lin-Chao</surname>, <given-names>S.</given-names></string-name> and <string-name><surname>Siddavattam</surname>, <given-names>D</given-names></string-name>. (<year>2020</year>) <article-title>Metabolic remodeling in Escherichia coli MG1655. A prophage e14-encoded small RNA, co293, post-transcriptionally regulates transcription factors HcaR and FadR</article-title>. <source>FEBS J.</source>, <volume>287</volume>, <fpage>4767</fpage>– <lpage>4782</lpage>.</mixed-citation></ref>
<ref id="c59"><label>59.</label><mixed-citation publication-type="journal"><string-name><surname>Gomes</surname>, <given-names>A.É.I.</given-names></string-name>, <string-name><surname>Stuchi</surname>, <given-names>L.P.</given-names></string-name>, <string-name><surname>Siqueira</surname>, <given-names>N.M.G.</given-names></string-name>, <string-name><surname>Henrique</surname>, <given-names>J.B.</given-names></string-name>, <string-name><surname>Vicentini</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Ribeiro</surname>, <given-names>M.L.</given-names></string-name>, <string-name><surname>Darrieux</surname>, <given-names>M.</given-names></string-name> and <string-name><surname>Ferraz</surname>, <given-names>L.F.C</given-names></string-name>. (<year>2018</year>) <article-title>Selection and validation of reference genes for gene expression studies in Klebsiella pneumoniae using Reverse Transcription Quantitative real-time PCR</article-title>. <source>Sci. Rep</source>., <volume>8</volume>, <fpage>1</fpage>–<lpage>14</lpage>.</mixed-citation></ref>
<ref id="c60"><label>60.</label><mixed-citation publication-type="journal"><string-name><surname>Sundaram</surname>, <given-names>V.K.</given-names></string-name>, <string-name><surname>Sampathkumar</surname>, <given-names>N.K.</given-names></string-name>, <string-name><surname>Massaad</surname>, <given-names>C.</given-names></string-name> and <string-name><surname>Grenier</surname>, <given-names>J</given-names></string-name>. (<year>2019</year>) <article-title>Optimal use of statistical methods to validate reference gene stability in longitudinal studies</article-title>. <source>PLoS One</source>, <volume>14</volume>, <fpage>e0219440</fpage>.</mixed-citation></ref>
<ref id="c61"><label>61.</label><mixed-citation publication-type="journal"><string-name><surname>Fu</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Yang</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Fan</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Zhao</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Du</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Shah</surname>, <given-names>S.M.A.</given-names></string-name>, <string-name><surname>Akram</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Rong</surname>, <given-names>R.</given-names></string-name> and <string-name><surname>Yang</surname>, <given-names>Y</given-names></string-name>. (<year>2020</year>) <article-title>Selection and validation of optimal endogenous reference genes for analysis of quantitative PCR in four tissues pathologically associated with Kidney-yang deficiency syndrome following influenza A infection</article-title>. <source>Exp. Ther. Med</source>., <volume>20</volume>, <fpage>1</fpage>–<lpage>1</lpage>.</mixed-citation></ref>
<ref id="c62"><label>62.</label><mixed-citation publication-type="journal"><string-name><surname>Szabó</surname>, <given-names>J.E.</given-names></string-name>, <string-name><surname>Surányi</surname>, <given-names>É.V.</given-names></string-name>, <string-name><surname>Mébold</surname>, <given-names>B.S.</given-names></string-name>, <string-name><surname>Trombitás</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Cserepes</surname>, <given-names>M.</given-names></string-name> and <string-name><surname>Tóth</surname>, <given-names>J</given-names></string-name>. (<year>2020</year>) <article-title>A user-friendly, high-throughput tool for the precise fluorescent quantification of deoxyribonucleoside triphosphates from biological samples</article-title>. <source>Nucleic Acids Res</source>., <volume>48</volume>, <fpage>e45</fpage>–<lpage>e45</lpage>.</mixed-citation></ref>
<ref id="c63"><label>63.</label><mixed-citation publication-type="journal"><string-name><surname>Krašovec</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Richards</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Gomez</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Gifford</surname>, <given-names>D.R.</given-names></string-name>, <string-name><surname>Mazoyer</surname>, <given-names>A.</given-names></string-name> and <string-name><surname>Knight</surname>, <given-names>C.G</given-names></string-name>. (<year>2019</year>) <article-title>Measuring microbial mutation rates with the fluctuation assay</article-title>. <source>J. Vis. Exp</source>., <volume>2019</volume>, <fpage>60406</fpage>.</mixed-citation></ref>
<ref id="c64"><label>64.</label><mixed-citation publication-type="journal"><string-name><surname>Yuan</surname>, <given-names>J.S.</given-names></string-name>, <string-name><surname>Reed</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>F.</given-names></string-name> and <string-name><surname>Stewart</surname>, <given-names>C.N</given-names></string-name>. (<year>2006</year>) <article-title>Statistical analysis of real-time PCR data</article-title>. <source>BMC Bioinformatics</source>, <volume>7</volume>, <fpage>85</fpage>.</mixed-citation></ref>
<ref id="c65"><label>65.</label><mixed-citation publication-type="journal"><string-name><surname>Crowley</surname>, <given-names>D.J.</given-names></string-name>, <string-name><surname>Boubriak</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Berquist</surname>, <given-names>B.R.</given-names></string-name>, <string-name><surname>Clark</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Richard</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Sullivan</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>DasSarma</surname>, <given-names>S.</given-names></string-name> and <string-name><surname>McCready</surname>, <given-names>S</given-names></string-name>. (<year>2006</year>) <article-title>The uvrA, uvrB and uvrC genes are required for repair of ultraviolet light induced DNA photoproducts in Halobacterium sp. NRC-1</article-title>. <source>Saline Systems</source>, <volume>2</volume>, <fpage>11</fpage>.</mixed-citation></ref>
<ref id="c66"><label>66.</label><mixed-citation publication-type="journal"><string-name><surname>O’Sullivan</surname>, <given-names>D.M.</given-names></string-name>, <string-name><surname>Hinds</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Butcher</surname>, <given-names>P.D.</given-names></string-name>, <string-name><surname>Gillespie</surname>, <given-names>S.H.</given-names></string-name> and <string-name><surname>McHugh</surname>, <given-names>T.D</given-names></string-name>. (<year>2008</year>) <article-title>Mycobacterium tuberculosis DNA repair in response to subinhibitory concentrations of ciprofloxacin</article-title>. <source>J. Antimicrob. Chemother</source>., <volume>62</volume>, <fpage>1199</fpage>–<lpage>1202</lpage>.</mixed-citation></ref>
<ref id="c67"><label>67.</label><mixed-citation publication-type="journal"><string-name><surname>Alland</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Steyn</surname>, <given-names>A.J.</given-names></string-name>, <string-name><surname>Weisbrod</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Aldrich</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Jacobs</surname>, <given-names>W.R.</given-names> and <suffix>Jr</suffix></string-name>. (<year>2000</year>) <article-title>Characterization of the Mycobacterium tuberculosis iniBAC promoter, a promoter that responds to cell wall biosynthesis inhibition</article-title>. <source>J. Bacteriol</source>., <volume>182</volume>, <fpage>1802</fpage>–<lpage>11</lpage>.</mixed-citation></ref>
<ref id="c68"><label>68.</label><mixed-citation publication-type="journal"><string-name><surname>Zhang</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Scorpio</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Nikaido</surname>, <given-names>H.</given-names></string-name> and <string-name><surname>Sun</surname>, <given-names>Z</given-names></string-name>. (<year>1999</year>) <article-title>Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of Mycobacterium tuberculosis to pyrazinamide</article-title>. <source>J. Bacteriol</source>., <volume>181</volume>, <fpage>2044</fpage>–<lpage>2049</lpage>.</mixed-citation></ref>
<ref id="c69"><label>69.</label><mixed-citation publication-type="journal"><string-name><surname>Romero</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Traxler</surname>, <given-names>M.F.</given-names></string-name>, <string-name><surname>López</surname>, <given-names>D.</given-names></string-name> and <string-name><surname>Kolter</surname>, <given-names>R</given-names></string-name>. (<year>2011</year>) <article-title>Antibiotics as Signal Molecules</article-title>. <source>Chem. Rev</source>., <volume>111</volume>, <fpage>5492</fpage>.</mixed-citation></ref>
<ref id="c70"><label>70.</label><mixed-citation publication-type="journal"><string-name><surname>Srinath</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Bharti</surname>, <given-names>S.K.</given-names></string-name> and <string-name><surname>Varshney</surname>, <given-names>U</given-names></string-name>. (<year>2007</year>) <article-title>Substrate specificities and functional characterization of a thermo-tolerant uracil DNA glycosylase (UdgB) from Mycobacterium tuberculosis</article-title>. <source>DNA Repair (Amst</source><italic>).</italic>, <volume>6</volume>, <fpage>1517</fpage>–<lpage>28</lpage>.</mixed-citation></ref>
<ref id="c71"><label>71.</label><mixed-citation publication-type="journal"><string-name><surname>Malshetty</surname>, <given-names>V.S.</given-names></string-name>, <string-name><surname>Jain</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Srinath</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Kurthkoti</surname>, <given-names>K.</given-names></string-name> and <string-name><surname>Varshney</surname>, <given-names>U</given-names></string-name>. (<year>2010</year>) <article-title>Synergistic effects of UdgB and Ung in mutation prevention and protection against commonly encountered DNA damaging agents in Mycobacterium smegmatis</article-title>. <source>Microbiology</source>, <volume>156</volume>, <fpage>940</fpage>–<lpage>9</lpage>.</mixed-citation></ref>
<ref id="c72"><label>72.</label><mixed-citation publication-type="journal"><string-name><surname>Castañeda-García</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Prieto</surname>, <given-names>A.I.</given-names></string-name>, <string-name><surname>Rodríguez-Beltrán</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Alonso</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Cantillon</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Costas</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Pérez-Lago</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Zegeye</surname>, <given-names>E.D.</given-names></string-name>, <string-name><surname>Herranz</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Plociński</surname>, <given-names>P.</given-names></string-name>, <etal>et al.</etal> (<year>2017</year>) <article-title>A non-canonical mismatch repair pathway in prokaryotes</article-title>. <source>Nat. Commun</source>., <volume>8</volume>, <fpage>14246</fpage>.</mixed-citation></ref>
<ref id="c73"><label>73.</label><mixed-citation publication-type="journal"><string-name><surname>Mathews</surname>, <given-names>C.K</given-names></string-name>. (<year>2006</year>) <article-title>DNA precursor metabolism and genomic stability</article-title>. <source>FASEB J</source>., <volume>20</volume>, <fpage>1300</fpage>–<lpage>14</lpage>.</mixed-citation></ref>
<ref id="c74"><label>74.</label><mixed-citation publication-type="journal"><string-name><surname>Nordman</surname>, <given-names>J.</given-names></string-name> and <string-name><surname>Wright</surname>, <given-names>A</given-names></string-name>. (<year>2008</year>) <article-title>The relationship between dNTP pool levels and mutagenesis in an Escherichia coli NDP kinase mutant</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A</source>., <volume>105</volume>, <fpage>10197</fpage>–<lpage>202</lpage>.</mixed-citation></ref>
<ref id="c75"><label>75.</label><mixed-citation publication-type="journal"><string-name><surname>Kumar</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Viberg</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Nilsson</surname>, <given-names>A.K.</given-names></string-name> and <string-name><surname>Chabes</surname>, <given-names>A</given-names></string-name>. (<year>2010</year>) <article-title>Highly mutagenic and severely imbalanced dNTP pools can escape detection by the S-phase checkpoint</article-title>. <source>Nucleic Acids Res</source>., <volume>38</volume>, <fpage>3975</fpage>–<lpage>83</lpage>.</mixed-citation></ref>
<ref id="c76"><label>76.</label><mixed-citation publication-type="journal"><string-name><surname>Yao</surname>, <given-names>N.Y.</given-names></string-name>, <string-name><surname>Schroeder</surname>, <given-names>J.W.</given-names></string-name>, <string-name><surname>Yurieva</surname>, <given-names>O.</given-names></string-name>, <string-name><surname>Simmons</surname>, <given-names>L.A.</given-names></string-name> and <string-name><surname>O’Donnell</surname>, <given-names>M.E</given-names></string-name>. (<year>2013</year>) <article-title>Cost of rNTP/dNTP pool imbalance at the replication fork</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A</source>., <volume>110</volume>, <fpage>12942</fpage>–<lpage>7</lpage>.</mixed-citation></ref>
<ref id="c77"><label>77.</label><mixed-citation publication-type="journal"><string-name><surname>Kurthkoti</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Kumar</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Jain</surname>, <given-names>R.</given-names></string-name> and <string-name><surname>Varshney</surname>, <given-names>U</given-names></string-name>. (<year>2008</year>) <article-title>Important role of the nucleotide excision repair pathway in Mycobacterium smegmatis in conferring protection against commonly encountered DNA-damaging agents</article-title>. <source>Microbiology</source>, <volume>154</volume>, <fpage>2776</fpage>–<lpage>85</lpage>.</mixed-citation></ref>
<ref id="c78"><label>78.</label><mixed-citation publication-type="journal"><string-name><surname>Ragheb</surname>, <given-names>M.N.</given-names></string-name>, <string-name><surname>Ford</surname>, <given-names>C.B.</given-names></string-name>, <string-name><surname>Chase</surname>, <given-names>M.R.</given-names></string-name>, <string-name><surname>Lin</surname>, <given-names>P.L.</given-names></string-name>, <string-name><surname>Flynn</surname>, <given-names>J.A.L.</given-names></string-name> and <string-name><surname>Fortune</surname>, <given-names>S.M</given-names></string-name>. (<year>2013</year>) <article-title>The mutation rate of mycobacterial repetitive unit loci in strains of M. tuberculosis from cynomolgus macaque infection</article-title>. <source>BMC Genomics</source>, <volume>14</volume>.</mixed-citation></ref>
<ref id="c79"><label>79.</label><mixed-citation publication-type="journal"><string-name><surname>Kucukyildirim</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Long</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Sung</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Miller</surname>, <given-names>S.F.</given-names></string-name>, <string-name><surname>Doak</surname>, <given-names>T.G.</given-names></string-name> and <string-name><surname>Lynch</surname>, <given-names>M</given-names></string-name>. (<year>2016</year>) <article-title>The Rate and Spectrum of Spontaneous Mutations in Mycobacterium smegmatis, a Bacterium Naturally Devoid of the Postreplicative Mismatch Repair Pathway</article-title>. <source>G3 (Bethesda)</source>., <volume>6</volume>, <fpage>2157</fpage>–<lpage>63</lpage>.</mixed-citation></ref>
<ref id="c80"><label>80.</label><mixed-citation publication-type="journal"><string-name><surname>Colangeli</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Arcus</surname>, <given-names>V.L.</given-names></string-name>, <string-name><surname>Cursons</surname>, <given-names>R.T.</given-names></string-name> and <string-name><surname>Karalus</surname>, <given-names>R.A</given-names></string-name>. (<year>2014</year>) <article-title>Whole Genome Sequencing of Mycobacterium tuberculosis Reveals Slow Growth and Low Mutation Rates during Latent Infections in Humans</article-title>. <source>PLoS One</source>, <volume>9</volume>, <fpage>91024</fpage>.</mixed-citation></ref>
<ref id="c81"><label>81.</label><mixed-citation publication-type="journal"><string-name><surname>David</surname>, <given-names>H.L</given-names></string-name>. (<year>1970</year>) <article-title>Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis</article-title>. <source>Appl. Microbiol</source>., <volume>20</volume>, <fpage>810</fpage>–<lpage>814</lpage>.</mixed-citation></ref>
<ref id="c82"><label>82.</label><mixed-citation publication-type="journal"><string-name><surname>Bergval</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Kwok</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Schuitema</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Kremer</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Soolingen</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Klatser</surname>, <given-names>P.</given-names></string-name> and <string-name><surname>Anthony</surname>, <given-names>R</given-names></string-name>. (<year>2012</year>) <article-title>Pre-existing isoniazid resistance, but not the genotype of Mycobacterium Tuberculosis drives rifampicin resistance codon preference in vitro</article-title>. <source>PLoS One</source>, <volume>7</volume>, <fpage>e29108</fpage>.</mixed-citation></ref>
<ref id="c83"><label>83.</label><mixed-citation publication-type="journal"><string-name><surname>Kohanski</surname>, <given-names>M.A.</given-names></string-name>, <string-name><surname>DePristo</surname>, <given-names>M.A.</given-names></string-name> and <string-name><surname>Collins</surname>, <given-names>J.J</given-names></string-name>. (<year>2010</year>) <article-title>Sublethal Antibiotic Treatment Leads to Multidrug Resistance via Radical-Induced Mutagenesis</article-title>. <source>Mol. Cell</source>, <volume>37</volume>, <fpage>311</fpage>–<lpage>320</lpage>.</mixed-citation></ref>
<ref id="c84"><label>84.</label><mixed-citation publication-type="journal"><string-name><surname>Briffotaux</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Liu</surname>, <given-names>S.</given-names></string-name> and <string-name><surname>Gicquel</surname>, <given-names>B</given-names></string-name>. (<year>2019</year>) <article-title>Genome-Wide Transcriptional Responses of Mycobacterium to Antibiotics</article-title>. <source>Front. Microbiol</source>., <volume>10</volume>, <fpage>249</fpage>.</mixed-citation></ref>
<ref id="c85"><label>85.</label><mixed-citation publication-type="journal"><string-name><surname>Dubnau</surname>, <given-names>D.</given-names></string-name> and <string-name><surname>Losick</surname>, <given-names>R</given-names></string-name>. (<year>2006</year>) <article-title>Bistability in bacteria</article-title>. <source>Mol. Microbiol</source>., <volume>61</volume>, <fpage>564</fpage>–<lpage>572</lpage>.</mixed-citation></ref>
<ref id="c86"><label>86.</label><mixed-citation publication-type="journal"><string-name><surname>Calgin</surname>, <given-names>M.K.</given-names></string-name>, <string-name><surname>Sahin</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Turegun</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Gerceker</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Atasever</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Koksal</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Karasartova</surname>, <given-names>D.</given-names></string-name> and <string-name><surname>Kiyan</surname>, <given-names>M</given-names></string-name>. (<year>2013</year>) <article-title>Expression analysis of efflux pump genes among drug-susceptible and multidrug-resistant Mycobacterium tuberculosis clinical isolates and reference strains</article-title>. <source>Diagn. Microbiol. Infect. Dis</source>., <volume>76</volume>, <fpage>291</fpage>–<lpage>297</lpage>.</mixed-citation></ref>
<ref id="c87"><label>87.</label><mixed-citation publication-type="journal"><string-name><surname>Machado</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Couto</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Perdigão</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Rodrigues</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Portugal</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Baptista</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Veigas</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Amaral</surname>, <given-names>L.</given-names></string-name> and <string-name><surname>Viveiros</surname>, <given-names>M</given-names></string-name>. (<year>2012</year>) <article-title>Contribution of Efflux to the Emergence of Isoniazid and Multidrug Resistance in Mycobacterium tuberculosis</article-title>. <source>PLoS One</source>, <volume>7</volume>, <fpage>e34538</fpage>.</mixed-citation></ref>
<ref id="c88"><label>88.</label><mixed-citation publication-type="journal"><string-name><surname>Li</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Mei</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Tang</surname>, <given-names>Q.</given-names></string-name>, <string-name><surname>Yu</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Cao</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Andongma</surname>, <given-names>B.T.</given-names></string-name>, <string-name><surname>Chou</surname>, <given-names>S.-H.</given-names></string-name> and <string-name><surname>He</surname>, <given-names>J</given-names></string-name>. (<year>2017</year>) <article-title>Transcriptome Landscape of Mycobacterium smegmatis</article-title>. <source>Front. Microbiol</source>., <volume>8</volume>, <fpage>2505</fpage>.</mixed-citation></ref>
<ref id="c89"><label>89.</label><mixed-citation publication-type="journal"><string-name><surname>Niki</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Niki</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Tateishi</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Ozeki</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Kirikae</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Lewin</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Inoue</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Matsumoto</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Dahl</surname>, <given-names>J.L.</given-names></string-name>, <string-name><surname>Ogura</surname>, <given-names>H.</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>) <article-title>A novel mechanism of growth phase-dependent tolerance to isoniazid in mycobacteria</article-title>. <source>J. Biol. Chem</source>., <volume>287</volume>, <fpage>27743</fpage>–<lpage>27752</lpage>.</mixed-citation></ref>
<ref id="c90"><label>90.</label><mixed-citation publication-type="journal"><string-name><surname>Wayne</surname>, <given-names>L.G.</given-names></string-name> and <string-name><surname>Diaz</surname>, <given-names>G.A</given-names></string-name>. (<year>1986</year>) <article-title>A double staining method for differentiating between two classes of mycobacterial catalase in polyacrylamide electrophoresis gels</article-title>. <source>Anal. Biochem</source>., <volume>157</volume>, <fpage>89</fpage>–<lpage>92</lpage>.</mixed-citation></ref>
<ref id="c91"><label>91.</label><mixed-citation publication-type="journal"><string-name><surname>Rai</surname>, <given-names>P</given-names></string-name>. (<year>2010</year>) <article-title>Oxidation in the nucleotide pool, the DNA damage response and cellular senescence: Defective bricks build a defective house</article-title>. <source>Mutat. Res</source>., <volume>703</volume>, <fpage>71</fpage>–<lpage>81</lpage>.</mixed-citation></ref>
<ref id="c92"><label>92.</label><mixed-citation publication-type="journal"><string-name><surname>Gon</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Napolitano</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Rocha</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Coulon</surname>, <given-names>S.</given-names></string-name> and <string-name><surname>Fuchs</surname>, <given-names>R.P</given-names></string-name>. (<year>2011</year>) <article-title>Increase in dNTP pool size during the DNA damage response plays a key role in spontaneous and induced-mutagenesis in Escherichia coli</article-title>. <source>Proc. Natl. Acad. Sci</source>., <volume>108</volume>, <fpage>19311</fpage>–<lpage>19316</lpage>.</mixed-citation></ref>
<ref id="c93"><label>93.</label><mixed-citation publication-type="journal"><string-name><surname>Wu</surname>, <given-names>M.-L.</given-names></string-name>, <string-name><surname>Gengenbacher</surname>, <given-names>M.</given-names></string-name> and <string-name><surname>Dick</surname>, <given-names>T</given-names></string-name>. (<year>2016</year>) <article-title>Mild Nutrient Starvation Triggers the Development of a Small-Cell Survival Morphotype in Mycobacteria</article-title>. <source>Front. Microbiol</source>., <volume>7</volume>, <fpage>947</fpage>.</mixed-citation></ref>
<ref id="c94"><label>94.</label><mixed-citation publication-type="journal"><string-name><surname>Rittershaus</surname>, <given-names>E.S.C.</given-names></string-name>, <string-name><surname>Baek</surname>, <given-names>S.-H.</given-names></string-name> and <string-name><surname>Sassetti</surname>, <given-names>C.M</given-names></string-name>. (<year>2013</year>) <article-title>The Normalcy of Dormancy: Common Themes in Microbial Quiescence</article-title>. <source>Cell Host Microbe</source>, <volume>13</volume>, <fpage>643</fpage>–<lpage>651</lpage>.</mixed-citation></ref>
<ref id="c95"><label>95.</label><mixed-citation publication-type="journal"><string-name><surname>Martomo</surname>, <given-names>S.A.</given-names></string-name> and <string-name><surname>Mathews</surname>, <given-names>C.K</given-names></string-name>. (<year>2002</year>) <article-title>Effects of biological DNA precursor pool asymmetry upon accuracy of DNA replication in vitro</article-title>. <source>Mutat. Res. - Fundam. Mol. Mech. Mutagen</source>., <volume>499</volume>, <fpage>197</fpage>–<lpage>211</lpage>.</mixed-citation></ref>
<ref id="c96"><label>96.</label><mixed-citation publication-type="journal"><string-name><surname>Schmidt</surname>, <given-names>T.T.</given-names></string-name>, <string-name><surname>Sharma</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Reyes</surname>, <given-names>G.X.</given-names></string-name>, <string-name><surname>Gries</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Gross</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Zhao</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Yuan</surname>, <given-names>J.-H.</given-names></string-name>, <string-name><surname>Wade</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Chabes</surname>, <given-names>A.</given-names></string-name> and <string-name><surname>Hombauer</surname>, <given-names>H</given-names></string-name>. (<year>2019</year>) <article-title>A genetic screen pinpoints ribonucleotide reductase residues that sustain dNTP homeostasis and specifies a highly mutagenic type of dNTP imbalance</article-title>. <source>Nucleic Acids Res</source>., <volume>47</volume>, <fpage>237</fpage>–<lpage>252</lpage>.</mixed-citation></ref>
<ref id="c97"><label>97.</label><mixed-citation publication-type="journal"><string-name><surname>Pancsa</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Fichó</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Molnár</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Surányi</surname>, <given-names>É.V.</given-names></string-name>, <string-name><surname>Trombitás</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Füzesi</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Lóczi</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Szijjártó</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Hirmondó</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Szabó</surname>, <given-names>J.E.</given-names></string-name>, <etal>et al.</etal> (<year>2022</year>) <article-title>dNTPpoolDB: a manually curated database of experimentally determined dNTP pools and pool changes in biological samples</article-title>. <source>Nucleic Acids Res</source>., <volume>50</volume>, <fpage>D1508</fpage>–<lpage>D1514</lpage>.</mixed-citation></ref>
<ref id="c98"><label>98.</label><mixed-citation publication-type="journal"><string-name><surname>Andersson</surname>, <given-names>S.G.E.</given-names></string-name> and <string-name><surname>Sharp</surname>, <given-names>P.M</given-names></string-name>. (<year>1996</year>) <article-title>Codon usage in the Mycobacterium tuberculosis complex</article-title>. <source>Microbiology</source>, <volume>142</volume>, <fpage>915</fpage>–<lpage>925</lpage>.</mixed-citation></ref>
<ref id="c99"><label>99.</label><mixed-citation publication-type="journal"><string-name><surname>Ssengooba</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>de Jong</surname>, <given-names>B.C.</given-names></string-name>, <string-name><surname>Joloba</surname>, <given-names>M.L.</given-names></string-name>, <string-name><surname>Cobelens</surname>, <given-names>F.G.</given-names></string-name> and <string-name><surname>Meehan</surname>, <given-names>C.J.</given-names></string-name> (<year>2016</year>) <article-title>Whole genome sequencing reveals mycobacterial microevolution among concurrent isolates from sputum and blood in HIV infected TB patients</article-title>. <source>BMC Infect. Dis</source>., <volume>16</volume>, <fpage>371</fpage>.</mixed-citation></ref>
<ref id="c100"><label>100.</label><mixed-citation publication-type="journal"><string-name><surname>Hakamata</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Takihara</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Iwamoto</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Tamaru</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Hashimoto</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Tanaka</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Kaboso</surname>, <given-names>S.A.</given-names></string-name>, <string-name><surname>Gebretsadik</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Ilinov</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Yokoyama</surname>, <given-names>A.</given-names></string-name>, <etal>et al.</etal> (<year>2020</year>) <article-title>Higher genome mutation rates of Beijing lineage of Mycobacterium tuberculosis during human infection</article-title>. <source>Sci. Rep</source>., <volume>10</volume>, <fpage>1</fpage>–<lpage>11</lpage>.</mixed-citation></ref>
<ref id="c101"><label>101.</label><mixed-citation publication-type="journal"><string-name><surname>Bates</surname>, <given-names>J.H.</given-names></string-name>, <string-name><surname>Stead</surname>, <given-names>W.W.</given-names></string-name> and <string-name><surname>Rado</surname>, <given-names>T.A</given-names></string-name>. (<year>1976</year>) <article-title>Phage type of tubercle bacilli isolated from patients with two or more sites of organ involvement</article-title>. <source>Am. Rev. Respir. Dis</source>., <volume>114</volume>, <fpage>353</fpage>–<lpage>358</lpage>.</mixed-citation></ref>
<ref id="c102"><label>102.</label><mixed-citation publication-type="journal"><string-name><surname>Boritsch</surname>, <given-names>E.C.</given-names></string-name> and <string-name><surname>Brosch</surname>, <given-names>R</given-names></string-name>. (<year>2017</year>) <article-title>Evolution of Mycobacterium tuberculosis: New insights into pathogenicity and drug resistance</article-title>. <source>Tuberc. Tuber. Bacillus Second Ed</source>., <pub-id pub-id-type="doi">10.1128/9781555819569.ch22</pub-id>.</mixed-citation></ref>
<ref id="c103"><label>103.</label><mixed-citation publication-type="journal"><string-name><surname>Braden</surname>, <given-names>C.R.</given-names></string-name>, <string-name><surname>Morlock</surname>, <given-names>G.P.</given-names></string-name>, <string-name><surname>Woodley</surname>, <given-names>C.L.</given-names></string-name>, <string-name><surname>Johnson</surname>, <given-names>K.R.</given-names></string-name>, <string-name><surname>Colombel</surname>, <given-names>A.C.</given-names></string-name>, <string-name><surname>Cave</surname>, <given-names>M.D.</given-names></string-name>, <string-name><surname>Yang</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Valway</surname>, <given-names>S.E.</given-names></string-name>, <string-name><surname>Onorato</surname>, <given-names>I.M.</given-names></string-name> and <string-name><surname>Crawford</surname>, <given-names>J.T</given-names></string-name>. (<year>2001</year>) <article-title>Simultaneous infection with multiple strains of Mycobacterium tuberculosis</article-title>. <source>Clin. Infect. Dis. an Off. Publ. Infect. Dis. Soc. Am</source>., <volume>33</volume>, <fpage>e42</fpage>–<lpage>47</lpage>.</mixed-citation></ref>
<ref id="c104"><label>104.</label><mixed-citation publication-type="journal"><string-name><surname>Martín</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Herranz</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Ruiz Serrano</surname>, <given-names>M.J.</given-names></string-name>, <string-name><surname>Bouza</surname>, <given-names>E.</given-names></string-name> and <string-name><surname>García de Viedma</surname>, <given-names>D.</given-names></string-name> (<year>2010</year>) <article-title>The clonal composition of Mycobacterium tuberculosis in clinical specimens could be modified by culture</article-title>. <source>Tuberculosis</source>, <volume>90</volume>, <fpage>201</fpage>–<lpage>207</lpage>.</mixed-citation></ref>
<ref id="c105"><label>105.</label><mixed-citation publication-type="book"><collab>World Health Organization</collab> (<year>2021</year>) <source>Global tuberculosis report 2021</source> <publisher-loc>Geneva</publisher-loc>.</mixed-citation></ref>
</ref-list>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.96695.1.sa3</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ali</surname>
<given-names>Musa</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Hawassa University</institution>
</institution-wrap>
<city>Hawassa</city>
<country>Ethiopia</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Incomplete</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Useful</kwd>
</kwd-group>
</front-stub>
<body>
<p>This <bold>useful</bold> study reports on the impact of antibiotic pressure on the genomic stability of the mc2155 strain of Mycobacterium smegmatis, a model for Mycobacterium tuberculosis. The study concludes that exposure to antibiotics did not lead to the emergence of new adaptive mutations in laboratory settings, contradicting the prevailing theory of antibiotic resistance development through drug-induced microevolution. While the genomic analysis provided detailed insights into the stability of M. smegmatis following exposure to standard TB treatment antibiotics, the evidence presented for antibiotic pressure not contributing to the occurrence of new adaptive mutations is still <bold>incomplete</bold>.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.96695.1.sa2</article-id>
<title-group>
<article-title>Reviewer #1 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>In this manuscript, Molnar, Suranyi and colleagues have probed the genomic stability of Mycobacterium smegmatis in response to several anti-tuberculosis drugs as monotherapy and in combination. Unlike the study by Nyinoh and McFaddden <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/ddr.21497">http://dx.doi.org/10.1002/ddr.21497</ext-link> (which should be cited), the authors use a sub-lethal dose of antibiotic. While this is motivated by sound technical considerations, the biological and therapeutic rationale could be further elaborated. The results the authors obtain are in line with papers examining the genomic mutation rate in vitro and from patient samples in Mycobacterium tuberculosis, in vitro in Mycobacterium smegmatis and in vitro in Mycobacterium tuberculosis (although the study by HL David (PMID: 4991927) is not cited). The results are confirmatory of previous studies. It is therefore puzzling why the authors propose the opposite hypothesis in the paper (i.e antibiotic exposure should increase mutation rates) merely to tear it down later. This straw-man style is entirely unnecessary. The results on the nucleotide pools are interesting, but the statistically significant data is difficult to identify as presented, and therefore the new biological insights are unclear. Finally, the authors show that a fluctuation assay generates mutations with higher frequencies that the genetic stability assays, confirming the well-known effect of phenotypic antibiotic resistance.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.96695.1.sa1</article-id>
<title-group>
<article-title>Reviewer #2 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>In this study, the authors assess whether selective pressure from drug chemotherapy influences the emergence of drug resistance through the acquisition of genetic mutations or phenotypic tolerance. I commend the authors on their approach of utilizing the mutation accumulation (MA) assay as a means to answer this and whole genome sequencing of clones from the assay convincingly demonstrates low mutation rates in Mycobacteria when exposed to sub-inhibitory concentrations of antibiotics. Also, quantitative PCR highlighted the upregulation of DNA repair genes in Mycobacteria following drug treatment, implying the preservation of genomic integrity via specific repair pathways.</p>
<p>Even though the findings stem from M. smegmatis exposure to antibiotics under in vitro conditions, this is still relevant in the context of the development of drug resistance so I can see where the authors' train of thought was heading in exploring this. However, I think important experiments to perform to more fully support the conclusion that resistance is largely associated with phenotypic rather than genetic factors would have been to either sequence clones from the ciprofloxacin tolerance assay (to show absence/ minimal genetic mutations) or to have tested the MIC of clones from the MA assay (to show an increase in MIC). There seems to be a disconnect between making these conclusions from experiments conducted under different conditions, or perhaps the authors can clarify why this was done. With regards to the sub-inhibitory drug concentration applied, there is significant variation in the viability as calculated by CFUs following the different treatments and there is evidence that cell death greatly affects the calculation of mutation rate (PMCID: PMC5966242). For instance, the COMBO treatment led to 6% viability whilst the INH treatment led to 80% cell viability. Are there any adjustments made to take this into account? It would also be useful to the reader to include a supplementary table of the SNPs detected from the lineages of each treatment - to determine if at any point rifampicin treatment led to mutations in rpoB, isoniazid to katG mutations, etc. Overall, while this study is tantalizingly suggestive of phenotypic tolerance playing a leading role in drug resistance (and perhaps genetic mutations a sub-ordinate role) a more substantial link is needed to clarify this.</p>
</body>
</sub-article>
<sub-article id="sa3" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.96695.1.sa0</article-id>
<title-group>
<article-title>Reviewer #3 (Public Review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>This manuscript describes how antibiotics influence genetic stability and survival in Mycobacterium smegmatis. Prolonged treatment with first-line antibiotics did not significantly impact mutation rates. Instead, adaptation to these drugs appears to be mediated by upregulation of DNA repair enzymes. While this study offers robust data, findings remain correlative and fall short of providing mechanistic insights.</p>
<p>Strengths:</p>
<p>The strength of this study is the use of genome-wide approaches to address the specific question of whether or not mycobacteria induce mutagenic potential upon antibiotic exposure.</p>
<p>Weaknesses:</p>
<p>The authors suggest that the upregulation of DNA repair enzymes ensures a low mutation rate under drug pressure. However, this suggestion is based on correlative data, and there is no mechanistic validation of their speculations in this study.</p>
<p>Furthermore, as detailed below, some of the statements made by the authors are not substantiated by the data presented in the manuscript.</p>
<p>Finally, some clarifications are needed for the methodologies employed in this study. Most importantly, reduced colony growth should be demonstrated on agar plates to indicate that the drug concentrations calculated from liquid culture growth can be applied to agar surface growth. Without such validations, the lack of induced mutation could simply be due to the fact that the drug concentrations used in this study were insufficient.</p>
</body>
</sub-article>
<sub-article id="sa4" article-type="author-comment">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.96695.1.sa4</article-id>
<title-group>
<article-title>Author response:</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Molnár</surname>
<given-names>Dániel</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Surányi</surname>
<given-names>Éva Viola</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Trombitás</surname>
<given-names>Tamás</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Füzesi</surname>
<given-names>Dóra</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hirmondó</surname>
<given-names>Rita</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tóth</surname>
<given-names>Judit</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0965-046X</contrib-id></contrib>
</contrib-group>
</front-stub>
<body>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #1:</bold></p>
</disp-quote>
<p>The phenomenon of stress-inducible mutagenesis in bacterial evolution remains a topic of heated debate. Consequently, the emergence of genetically encoded resistance may stem from either microevolution or the dissemination of pre-existing variants from polyclonal infections under drug pressure. We believe that the Introduction presents both of these hypotheses in a balanced manner to elucidate the rationale behind our mutation accumulation investigations.</p>
<p>While we acknowledge the well-known existence of phenotypic antibiotic resistance, it's worth noting that conclusions regarding mutation rates are often drawn from fluctuation assays without confirmation of genetic-level changes. This discrepancy persists despite fluctuation assays accounting for both phenotypic and genotypic alterations. Combining genome sequencing with fluctuation assays underscores the importance of making this distinction.</p>
<p>Thank you for the suggestion regarding improving the figures; we will incorporate these changes accordingly in the revised version. Additionally, we will address the rationale for using sub-lethal doses of antibiotics and compare our results with the referenced papers.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #2:</bold></p>
</disp-quote>
<p>Thank you for acknowledging the values of the manuscript and for the insightful suggestions for improvement. We agree on the necessity to directly connect the mutation accumulation experiments with the tolerance assay, and we have already initiated additional experiments to integrate into a revised version.</p>
<p>We also agree with and have been aware of the notion that cell death affects the calculation of the mutation rate. However, the error in the estimation of the generation time leads to an overestimation of the mutation rate, which, in our case, reinforces the conclusion that no discernible increase in mutation rate occurs in our mutation accumulation experiment. In the revised version, we aim to address i) the source of variation in cell death degree and ii) its influence on calculations.</p>
<p>The SNPs identified from the lineages of each treatment are compiled in the &quot;unique muts.xls&quot; file within the Figshare document bundle we included with the manuscript. We regret not providing a detailed reference to this in the manuscript; instead, the Figshare files were merely mentioned under the Data Availability section (No. 6) without specifics. As advised, we will create a supplementary table containing this data.</p>
<disp-quote content-type="editor-comment">
<p><bold>Reviewer #3:</bold></p>
</disp-quote>
<p>Thank you for appreciating the manuscript's merits and for the instructive suggestions (also articulated in the specific comments). We agree that we should show the data on reduced colony growth on agar plates to demonstrate that the drug concentrations used in the study are relevant. We will include this in the revised version, as well as changes in response to all specific comments.</p>
<p>We acknowledge that the observed upregulation of DNA repair enzymes and the low mutation rates under drug pressure represent correlative data. Therefore, we opted against presenting the qPCR results as a mechanistic explanation. In the manuscript, we carefully stated: &quot;The observed upregulation of the relevant DNA repair enzymes might account for the low mutation rate even under drug pressure.&quot; We did not establish a mechanistic link or emphasize the repair activation in the title, abstract, or discussion. We recognize the necessity for a new series of targeted experiments to provide mechanistic explanations. In this paper, our aim is to convincingly demonstrate that antibiotic pressure did not induce the occurrence of new adaptive mutations.</p>
</body>
</sub-article>
</article>